Hydrogen embrittlement inhibitors and methods
By using terminal alkynes and olefin compounds as hydrogen embrittlement inhibitors and flavoring agents, the problems of inconsistent hydrogen embrittlement inhibitor concentrations and safety risks in existing technologies are solved, achieving safe and effective hydrogen embrittlement inhibition and easy removal, making it suitable for hydrogen transportation and storage.
Patent Information
- Application Number
- CN202580025675.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-04-09
- Filing Date
- 2025-04-08
- Publication Date
- 2026-11-17
AI Technical Summary
Existing hydrogen embrittlement inhibitors do not meet the concentration requirements of hydrogen fuel standards and may pose safety risks or affect fuel cell performance. They are also difficult to effectively suppress hydrogen embrittlement in the gas phase and are easy to remove.
Terminal alkynes and terminal olefins are used as hydrogen embrittlement inhibitors and flavoring agents. They are formed by contacting hydrogen to create a treated fluid for use in fuel cells and pipeline transportation, ensuring that the concentration meets standards and is non-toxic and harmless.
It effectively suppresses hydrogen embrittlement, meets hydrogen fuel standards, does not affect fuel cell performance, is easy to remove, safe and non-toxic, and is suitable for hydrogen transportation and storage.
Smart Images

Figure CN123125307A_ABST
Abstract
Description
Citation of relevant applications
[0001] This application was filed on April 8, 2025 as a PCT international patent application and claims the benefit and priority of U.S. Provisional Patent Application Nos. 63 / 631,544 and 63 / 631,556, filed on April 9, 2024, the disclosure of which is incorporated herein by reference in its entirety. Technical Field
[0002] This disclosure relates to compounds, such as terminal alkynes and terminal alkenes, that can be used as flavoring agents and / or hydrogen embrittlement inhibitors; compositions comprising flavoring agents and / or hydrogen embrittlement inhibitors; and methods of transporting or storing fluids comprising flavoring agents and / or hydrogen embrittlement inhibitors. Background Technology
[0003] Hydrogen embrittlement (HE), also known as hydrogen-assisted cracking or hydrogen-induced cracking (HIC), leads to a decrease in the ductility of metals, usually due to the absorption of hydrogen. Hydrogen atoms are very small and can penetrate into solid metals. Once absorbed, hydrogen reduces the stress required for crack initiation and propagation in the metal, which can lead to embrittlement. Hydrogen embrittlement can occur in a variety of metals or metal-containing materials, including but not limited to aluminum, cobalt, copper, iron, nickel, titanium and their alloys, such as steel, stainless steel, carbon steel, X80 / L555 steel, X70 / L485 steel, X65 / L450 steel, X52 / L360 steel, X42 / L290 steel, J55 and J55N steel, N80-P110 steel, L80 steel, K55 steel, API55T steel, A 606-T4 steel and ANSI 4130 steel, alloy steels (e.g., nickel steel, nickel-chromium steel, nickel (carburized) steel, chromium-vanadium steel, austenitic chromium-nickel steel, silicon steel and silicon-manganese spring steel), as well as high-strength 7xxx series (Al-Zn-Mg-Cu alloys) aluminum-based alloys, α / β titanium alloys, Alloy 716, Alloy 725, Alloy 625 Grade 1, Alloy 718, Udimet® 700, Rene® 41. Hastelloy® X and TD-NiCr nickel-based alloys, L-605 and Zimaloy cobalt-based alloys, MP35N nickel-cobalt-based alloys, and iron-based alloys (A-286). Suppressing hydrogen embrittlement is crucial for the transport of hydrogen in pipelines.
[0004] Hydrogen embrittlement inhibition has been studied (“Hydrogen Embrittlement and Its Control in Hydrogen-Fueled Engine Systems,” Conference Paper, NASA, January 1, 1978; Int. J. Hydrogen Energy, 10(7 / 8), 551-554, 1985). Oxygen (O2), carbon monoxide (CO), nitric oxide (N2O), sulfur dioxide (SO2), and carbon disulfide (CS2) have been reported to have inhibitory properties for hydrogen embrittlement. However, the concentrations of these gases required for effective inhibition of embrittlement do not meet various hydrogen fuel quality standards, such as ISO 14687:2019. Furthermore, these compounds may pose safety risks when used as embrittlement inhibitors (e.g., they may be explosive, corrosive, toxic to humans, etc.). One or more of these drawbacks limit the use of these materials outside of highly controlled environments and / or mission-critical applications.
[0005] Several organic compounds have been proposed as hydrogen embrittlement inhibitors. For example, US3345298 discloses the use of chloroethynyl alcohol in sulfuric acid solution, but this reference does not disclose or recommend its use in the gas phase. Furthermore, the permissible concentration of halogenated compounds specified in the hydrogen fuel quality standard (ISO 14687:2019) is only 0.05 µm / mol H2; if chloroated compounds are used as embrittlement inhibitors in H2 gas applications, this concentration may be exceeded. The high water solubility of these compounds also does not comply with the ISO 13734:2013 natural gas flavoring standard.
[0006] Ethyl mercaptan has been reported as a hydrogen embrittlement inhibitor in the gas phase. Gaseous Hydrogen Embrittlement of Materials in Energy Technologies Mechanisms, Modeling and Future Developments (Woodhead Publishing Series in Metals and Surface Engineering, Volume 1, 2012, 129-153). However, the required concentration does not meet the hydrogen fuel sulfur specifications (total sulfur less than 0.004 µm / mol H2) as defined in ISO 14687:2019.
[0007] Propylene alcohol has been reported as a hydrogen embrittlement inhibitor in hydrochloric acid solution, but not in the gas phase (Corrosion, 46(5), 354–359, 1990). Propylene alcohol is reportedly unsuitable for this application due to its toxicity, and its high water solubility does not meet certain standards, such as ISO 13734:2013.
[0008] Other organic molecules have been reported to reduce or prevent hydrogen embrittlement in various aqueous media (see Corrosion Science, 37(1), 1739-1750, 1995; Corrosion, 54(3), 187-193, 1998; British Corrosion Journal, 35(3), 204-209 (2000); Corrosion Engineering, Science and Technology, 49(2), 130-135, 2014). However, the use of these organic molecules in the gas phase has not been published or recommended, likely because the molecular weight and physicochemical properties of these compounds would make it difficult (if not impossible) to inject and / or retain them in the gas phase at sufficient concentrations to suppress embrittlement.
[0009] Flavorings have been added to fluids, including various hazardous gases, for decades. Flavorings can detect leaks without the need for external equipment. They can also be used to detect leaks in locations where detectors are difficult or impossible to place, such as outdoors. Because flavorings are easily detected by the human olfactory system, even small fluid leaks can be easily detected. It would be advantageous to provide a compound, such as an organic compound, that can act as both a hydrogen embrittlement inhibitor and a flavoring agent.
[0010] One promising application of hydrogen is hydrogen fuel cells. Hydrogen fuel cells typically use noble metals to electrochemically oxidize hydrogen at the anode of the cell. If the active sites of the noble metal are occupied by molecules other than hydrogen, the activity of the catalyst, as well as the efficiency and performance of the fuel cell, will decrease dramatically. This is often referred to as catalyst poisoning or deactivation, and it can be particularly problematic when using sulfur-based flavorings such as tetrahydrothiophene (THT) and tert-butyl mercaptan (TBM) (see International Journal of Hydrogen Energy, 41(28), 12231-12241, 2016; Journal of Power Sources, 152, 226–232, 2005). It would be advantageous to provide a compound, such as an organic compound, that can act as a hydrogen embrittlement inhibitor and does not adversely affect the performance of the fuel cell and / or deactivate the catalyst.
[0011] In some cases, it may be necessary to remove flavorings from hydrogen energy systems to prevent their release into the environment. If fuel cell exhaust is unfiltered, flavorings can be released into the environment, making potential hydrogen leaks undetectable or causing false leak alarms. Similarly, applications requiring ultrapure hydrogen may require the removal of flavorings from the hydrogen. It would be advantageous to provide a compound, such as an organic compound, that acts as a hydrogen embrittlement inhibitor and can be readily removed from fluids like hydrogen.
[0012] There is still a need to improve methods for suppressing hydrogen embrittlement, including identifying and utilizing compounds that: (i) can be used as flavoring agents for fluids such as hydrogen (e.g., have very low odor perception, distinctive odor characteristics and / or warning characteristics), (ii) do not adversely affect the performance of various devices such as fuel cells, (iii) can be easily removed from fluids such as hydrogen, (iv) are non-toxic to humans and / or the environment, and / or (v) combinations thereof. Summary of the Invention
[0013] This summary is provided to introduce, in a simplified form, various concepts that will be further described in the following detailed description. This summary is not intended to identify essential or necessary features of the claimed subject matter, nor is it intended to limit the scope of the claimed subject matter.
[0014] In one aspect, compounds are provided, including compounds that act as inhibitors of hydrogen embrittlement. Alternatively or additionally, the compounds may be flavoring agents for fluids (such as gases). The compounds may comprise terminal alkynes and terminal olefins, such as their substituted derivatives.
[0015] In another aspect, a composition is provided that may comprise a hydrogen embrittlement inhibitor, a flavoring agent, or a combination thereof. In some embodiments, the composition comprises one or more compounds provided herein, such as terminal alkynes or terminal olefins, and additives. Additives may include odorous compounds, stabilizers, diluents, or combinations thereof.
[0016] On the other hand, processed fluid compositions are provided, which may comprise a fluid (e.g., a gas) and any one or more compounds or compositions provided herein. The compounds or compositions may be dispersed in the fluid.
[0017] On the other hand, methods for treating fluids are provided. In some embodiments, the methods include providing a fluid and contacting (i) the fluid (e.g., a gas) with (ii) one or more compounds (e.g., terminal alkynes and terminal olefins) or compositions provided herein to form a treated fluid.
[0018] On the other hand, methods for generating energy are provided. In some embodiments, the method includes providing a fuel cell comprising an anode, and contacting the anode with the treated fluid composition described herein. Contact between the anode and the treated fluid may produce an oxidized treated fluid. The method may further include removing compounds, such as terminal alkynes and / or terminal olefins, from the treated fluid composition, the oxidized treated fluid composition, or both the treated fluid composition and the oxidized treated fluid composition.
[0019] In another aspect, a method for transporting or storing a treated fluid composition is also provided. The method may include providing one or more of the treated fluid compositions described herein, and placing the treated fluid composition in a device at least partially formed of metal. The device may include conduits. Compounds present in the treated fluid composition, such as terminal alkynes or compositions, may prevent or delay hydrogen embrittlement of the metal.
[0020] In another additional aspect, a system is also provided. In some embodiments, the system includes (i) a sensor, and (ii) a compound provided herein, such as a terminal alkyne, or a composition thereof. The sensor may be configured to allow the use of any compound provided herein, such as a terminal alkyne, at a concentration undetectable by the average person.
[0021] Other aspects will be set forth in part in the description which follows, and in part will be apparent from the description, or may be learned by practicing the aspects described herein. The advantages described herein can be realized and obtained by the elements and combinations particularly pointed out in the appended claims. It should be understood that the foregoing general description and the following detailed description are exemplary and illustrative only, and not restrictive. Attached Figure Description
[0022] Figure 1 The relationship between the concentration (ppm) of 1,6-heptaacetylene in hydrogen and time was plotted during a stability test conducted at 90 °C.
[0023] Figure 2 The graph depicts the relationship between the concentration (ppm) of cis-2-pentene in hydrogen and time during a stability test conducted at 90 °C.
[0024] Figure 3 The relationship between the concentration (ppm) of 2-pentyne in hydrogen and time was plotted during a stability test conducted at 90 °C.
[0025] Figure 4 The durability test results of a proton exchange membrane fuel cell (PEMFC) implementation using hept-2-yne as a hydrogen flavoring agent are described.
[0026] Figure 5The durability test results of a PEMFC implementation using hept-3-yne as a hydrogen flavoring agent are depicted.
[0027] Figure 6 The durability test results of a PEMFC implementation using oct-4-yne as a hydrogen flavoring agent are depicted.
[0028] Figure 7 The durability test results of a PEMFC implementation using hex-1-yne as a hydrogen flavoring agent are depicted.
[0029] Figure 8 The durability test results of a PEMFC implementation using 1-hexene-5-yne as a hydrogen flavoring agent are depicted.
[0030] Figure 9 The durability test results of a PEMFC implementation using hept-1-en-6-yne as a hydrogen flavoring agent are depicted.
[0031] Figure 10 The durability test results of a PEMFC implementation using 3,3-dimethylbut-1-yne as a hydrogen flavoring agent are depicted.
[0032] Figure 11 The durability test results of a PEMFC implementation using hex-1,5-diene as a hydrogen flavoring agent are depicted.
[0033] Figure 12 The durability test results of a PEMFC implementation using hex-1-ene as a hydrogen flavoring agent are depicted.
[0034] Figure 13 The durability test results of a PEMFC implementation using hex-2-ene as a hydrogen flavoring agent are depicted.
[0035] Figure 14 The durability test results of a PEMFC implementation using butyraldehyde as a hydrogen flavoring agent are presented.
[0036] Figure 15 The durability test results of a PEMFC implementation using tetrahydrothiophene (THT) as a hydrogen flavoring agent are depicted.
[0037] definition To more clearly define the terms used herein, the following definitions are provided. Unless otherwise specified, the following definitions apply to this disclosure. If a term is used in this disclosure but is not specifically defined herein, the definition in the IUPAC Chemical Terminology Compendium, 2nd Edition (1997) may be applied, provided that the definition does not conflict with any other disclosure or definition applied herein, or render any technical solution to which the definition is applied ambiguous or invalid. If any definition or usage provided in any document incorporated herein by reference conflicts with the definition or usage provided herein, the definition or usage provided herein shall prevail.
[0038] Because various features of the subject matter of this disclosure have been described, one or more combinations of different features may be contemplated within a particular aspect. For each aspect of each feature disclosed herein, all combinations are considered, whether or not a particular combination is explicitly described, provided they do not adversely affect the design, composition, system, process, or method described herein. Therefore, unless expressly stated to the contrary, any aspect of the features disclosed herein may be combined to describe and disclose an inventive design, composition, system, process, or method consistent with the entire disclosure.
[0039] Although compositions and methods are described as “comprising” various components or steps, unless otherwise stated, compositions and methods may also be “substantially composed of various components or steps” or “consisting of various components or steps”.
[0040] Unless otherwise specified, the terms “including,” “with,” and “having” as used herein are defined as encompassing (i.e., open-ended language).
[0041] The terms “a / an” and “described” are intended to include plural alternatives, such as at least one / an. For example, unless otherwise stated, the disclosure of “fluid,” “sensor,” etc., is intended to include mixtures or combinations of one or more fluids, sensors, etc.
[0042] This document discloses various numerical ranges. When an applicant discloses or claims protection for any type of range, unless otherwise indicated, the applicant's intent is to individually disclose or claim protection for every possible number that such range can reasonably cover, including the endpoints of the range and any subranges and combinations thereof covered therein. For example, by disclosing approximately 5 mg / m 3 n to approximately 20 mg / m 3 The applicant's intention is to list the concentration range of n separately for 5 mg / m 3 n, 6 mg / m 3 n, 7 mg / m 3 n, 8 mg / m 3 n, 9 mg / m 3n, 10 mg / m 3 n, 11 mg / m 3 n, 12 mg / m 3 n, 13 mg / m 3 n, 14 mg / m 3 n, 15 mg / m 3 n, 16 mg / m 3 n, 17 mg / m 3 n, 18 mg / m 3 n, 19 mg / m 3 n and 20 mg / m 3 n, including any subranges and combinations thereof, and these methods of describing such ranges are interchangeable. Furthermore, all numerical endpoints of the ranges disclosed herein are approximate unless otherwise specified. As a representative example, if an applicant states that one or more steps in the process disclosed herein can be performed at temperatures ranging from 10°C to 75°C, unless otherwise stated, this range should be interpreted as covering temperatures “about” 10°C to “about” 75°C.
[0043] Values or ranges herein may be expressed as “about,” from “about” a specific value, and / or to “about” another specific value. When expressing such values or ranges, other disclosed embodiments include the specific value, from one specific value, and / or to another specific value. Similarly, when a value is expressed as an approximation using the antecedent “about,” it should be understood that the specific value forms another embodiment. It should also be understood that numerous values are disclosed herein, and each value, in addition to being stated as the specific value, is also disclosed herein as “about” the stated value. On the other hand, each use of the term “about” may independently represent ±20% of the value, ±15% of the value, ±10% of the value, ±5% of the value, or ±3% of the value.
[0044] Therefore, if the applicant chooses to claim protection for less than the full extent of the disclosure for any reason, such as considering references that the applicant might not have been aware of at the time of filing the application, the applicant reserves the right to specify or exclude any individual member of any such group of values or ranges (including any subranges or combinations of subranges within that group) that can be claimed based on the scope or in any similar manner. Furthermore, if the applicant chooses to claim protection for less than the full extent of the disclosure for any reason, such as considering references or prior disclosures that the applicant might not have been aware of at the time of filing the application, the applicant reserves the right to specify or exclude any individual substituent, analogue, compound, ligand, structure, or group thereof, or any member of the claimed group.
[0045] For any particular compound or group disclosed herein, unless otherwise stated, any name or structure presented (general or specific) is intended to cover all conformational isomers, regio isomers, stereoisomers, and mixtures thereof that can be produced by a particular set of substituents. Unless otherwise specified, the name or structure also covers all enantiomers, diastereomers, and other optical isomers (if any), whether enantiomers or racemic forms, and mixtures of stereoisomers, as known to those skilled in the art. For example, general references to “C6 alkane,” “hexane,” or “hexanes” include n-hexane, 2-methylpentane, 3-methylpentane, 2,2-dimethylbutane, and 2,3-dimethylbutane; and general references to “C4 alkyl” or “butyl” include n-butyl, sec-butyl, isobutyl, and tert-butyl.
[0046] When used to describe a group, such as when referring to a substituted analogue of a particular group, the term "substituted" is intended to describe a compound or group in which any non-hydrogen moiety formally replaces one or more hydrogen atoms in the group or compound, and is intended to be non-limiting. A compound or group may also be referred to herein as "unsubstituted" or equivalent terms such as "non-substituted," referring to the original group or compound. "Substituted" is intended to be non-limiting and includes inorganic or organic substituents as specified and understood by one of ordinary skill in the art.
[0047] Unless otherwise stated, the terms "contact product," "contact," etc., are used herein to describe compositions and methods in which components are contacted together in any order, in any manner, and for any duration. For example, components may be contacted by blending or mixing. Furthermore, unless otherwise stated, contact of any components may occur with or without any other components of the compositions and methods described herein. Additional materials or components may be combined by any suitable method. Additionally, the term "contact product" includes mixtures, blends, solutions, slurries, reaction products, etc., or combinations thereof. Although "contact product" may and often includes reaction products, it does not require that the individual components react with each other. Similarly, "contacting" two or more components can produce reaction products or reaction mixtures. Thus, depending on the specific circumstances, "contact product" can be a mixture, a reaction mixture, or a reaction product.
[0048] The term "alkyl" is used herein according to the definition given by IUPAC: a monovalent group formed by removing a hydrogen atom from an alkane. Unless otherwise specified, an alkyl group can be straight-chain or branched.
[0049] As used herein, “cycloalkanes” refers to saturated cyclic hydrocarbons with or without side chains, such as cyclobutane, cyclopentane, cyclohexane, methylcyclopentane, and methylcyclohexane. Other identifiers may be used to indicate the presence of a specific group (if any) in a cycloalkane (e.g., halocycloalkanes indicate the presence of one or more halogen atoms that replace an equal amount of hydrogen atoms in the cycloalkane).
[0050] The term "hydrocarbon group" is used herein according to the definition prescribed by IUPAC: a monovalent group (i.e., a group containing only carbon and hydrogen) formed by removing a hydrogen atom from a hydrocarbon. Therefore, hydrocarbon groups include alkyl (straight-chain or branched), cycloalkyl, alkenyl, aryl, etc. Non-limiting examples of hydrocarbon groups include methyl, ethyl, butyl, hexyl, phenyl, tolyl, propenyl, etc.
[0051] When used in this document for the selection of substituents, the term "independently" refers to substituents selected from two different labels within the same pool of substituents, such as R. 1 and R 2 They can be the same or different.
[0052] This abstract is not intended to interpret the scope of the claims or limit the scope of the subject matter disclosed herein, but is intended to satisfy 37 CFR. The requirements of 1.72(b) are to enable the U.S. Patent and Trademark Office and the public to quickly determine the nature and purpose of the technical disclosure through a cursory examination. Furthermore, any headings used herein are not intended to interpret the scope of the claims or limit the scope of the subject matter disclosed herein.
[0053] All disclosures mentioned herein are incorporated herein by reference for the purpose of describing and disclosing, for example, the constructs and methods described in the disclosures, which can be used in conjunction with the present invention. The publications discussed throughout are provided solely for their disclosure prior to the filing date of this application. Nothing herein shall be construed as an admission that the inventor has no right to any prior disclosure due to a prior invention.
[0054] Those skilled in the art will readily recognize that various modifications can be made to the exemplary embodiments disclosed herein without substantially departing from the novel teachings and advantages of this disclosure. Therefore, all such modifications and equivalents are intended to be included within the scope of this disclosure as defined in the following claims. Accordingly, it should be understood that various other aspects, embodiments, modifications, and equivalents will arise in those skilled in the art upon reading the description herein without departing from the spirit of this disclosure or the scope of the appended claims. Detailed Implementation
[0055] This disclosure relates to flavoring agents, hydrogen embrittlement inhibitors, compositions, and methods for handling and / or transporting or storing materials such as fluids (which may include fuel gases).
[0056] Flavoring agents / hydrogen embrittlement inhibitors This document provides compounds, such as those that can be used as hydrogen embrittlement inhibitors, fluid flavoring agents, or combinations thereof. A compound is a hydrogen embrittlement inhibitor when it has a positive substitution effect. A compound acts as an embrittlement inhibitor when its presence improves the fracture toughness of a metal or alloy in contact with hydrogen.
[0057] These compounds may be non-toxic (e.g., non-toxic to humans or mammals) or have a detectable odor at levels below toxicity. The compounds may be environmentally harmless and will not pose health or toxicity problems to humans or other biological species. The combustion products of the compounds may also be environmentally harmless. The compounds may be harmless to components of a device system or equipment (e.g., piping, combustion systems, fuel cells, or any other system, device, or process).
[0058] In some embodiments, the compound comprises a terminal olefin. The phrase "terminal olefin" generally refers to an organic compound, including substituted derivatives of organic compounds and / or heteroatom-containing organic compounds, which include terminal double bonds, as described in the following sections: The term "substituted derivative" of an organic compound (including terminal alkenes) can include compounds having organic or inorganic substituents. In some embodiments, the substituted derivative of an organic compound includes an oxygen substituent.
[0059] Terminal olefins may contain heteroatoms, such as oxygen and nitrogen. When a terminal olefin contains oxygen as a heteroatom, oxygen can exist as part of the ether moiety.
[0060] In some embodiments, the terminal olefin includes terminal C3-C... 20 Alkenes, terminal C3-C 19 Alkenes, terminal C3-C 18 Alkenes, terminal C3-C 17 Alkenes, terminal C3-C 16 Alkenes, terminal C3-C 15 Alkenes, terminal C3-C 14 Alkenes, terminal C3-C 13 Alkenes, terminal C3-C 12 Alkenes, terminal C3-C 11 Alkenes, terminal C3-C 10Olefins, terminal C3-C9 olefins, terminal C3-C8 olefins, or terminal C3-C7 olefins. In some embodiments, the terminal olefin is hept-1-ene (1-heptene), hex-1-ene (1-hexene), or oct-1-ene (1-octene).
[0061] In some embodiments, the compound may include hexene, hepten, octene, or combinations thereof. The term "hepten" refers to a straight-chain compound comprising at least one double bond and seven carbon atoms, wherein at least two of the seven carbon atoms are bonded together by double bonds, and includes substituted derivatives thereof. The term "octene" refers to a straight-chain compound comprising at least one double bond and eight carbon atoms, wherein at least two of the eight carbon atoms are bonded together by double bonds, and includes substituted derivatives thereof. Substituted derivatives of hepten and octene include, but are not limited to, C1-C2 substituted hepten or C1-C2 substituted octene. For example, the table below shows general schematic diagrams of embodiments of a seven-carbon straight-chain heptenene and embodiments of C1-substituted heptenene.
[0062] Terminal olefins may contain one or more double bonds. When a terminal olefin contains two double bonds, the compound may be referred to as a "diene". In some embodiments, dienes include hexadiene or octadiene. The term "hexadiene" refers to a compound comprising a straight chain containing at least two double bonds and six carbon atoms, wherein at least four of the seven carbon atoms are bonded together by triple bonds, and includes substituted derivatives thereof. In some embodiments, hexadiene includes hex-1,5-diene, wherein 1 and 5 refer to the first and second carbon atoms and the fifth and sixth carbon atoms, respectively, in a straight chain of seven carbon atoms bonded together by double bonds. In some embodiments, octadiene includes oct-1,7-diene, wherein 1 and 7 refer to the first and second carbon atoms and the seventh and eighth carbon atoms, respectively, in a straight chain of eight carbon atoms bonded together by double bonds. Substituted derivatives of hexadiene or octadiene include, but are not limited to, C1-C2 substituted heptaadiene or C1-C2 substituted octadiene.
[0063] In some embodiments, the terminal olefin includes but-1,3-diene (1,3-butadiene). In some embodiments, the terminal olefin includes hex-1,5-diene (1,5-hexadiene). In some embodiments, the terminal olefin includes hepta-1,6-diene (1,6-heptadiene). In some embodiments, the terminal olefin includes oct-1,7-diene (1,7-octadiene).
[0064] In some embodiments, the terminal olefin includes compounds of formula (A): Where m is an integer selected from 0 to 4.
[0065] In some embodiments, heptaadiene and / or octadiene comprise compounds of formula (B): Where m is an integer selected from 0 to 4, such as 2 or 3 (for example, m is 2 for hepadiene and 3 for octadiene).
[0066] In some embodiments, heptaadiene and / or octadiene comprise compounds of formula (C): Where m and n are independently integers from 0 to 4; wherein, in some embodiments, m is 0, 1, 2 or 3, and n is 0, 1, 2 or 3; wherein, for example, for hepadiene, m + n = 2, and for octadiene, m + n = 3.
[0067] In some embodiments, the terminal olefin includes compounds of formula (D): Where n is an integer selected from 0 to 5 or 0 to 4; and where R 1 Selected from hydrogen, C1-C6 alkyl groups, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc. Alternatively, R 1 Optional from C3-C 12 cycloalkyl, C3-C 10 Cycloalkyl or C3-C7 cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, etc.
[0068] In some embodiments, the compound comprises a terminal alkyne. The phrase "terminal alkyne" generally refers to an organic compound, including substituted derivatives of organic compounds and / or heteroatom-containing organic compounds, which include a terminal triple bond, as described in the following sections: The term "substituted derivative" of an organic compound (including terminal alkynes) can include compounds having organic or inorganic substituents. In some embodiments, the substituted derivative of an organic compound includes an oxygen substituent.
[0069] In some embodiments, the terminal alkyne includes terminal C3-C 20 Alkynes, terminal C3-C 19 Alkynes, terminal C3-C 18 Alkynes, terminal C3-C 17 Alkynes, terminal C3-C 16 Alkynes, terminal C3-C 15 Alkynes, terminal C3-C 14 Alkynes, terminal C3-C 13Alkynes, terminal C3-C 12 Alkynes, terminal C3-C 11 Alkynes, terminal C3-C 10 Alkynes, terminal C3-C9 alkynes, terminal C3-C8 alkynes, or terminal C3-C7 alkynes.
[0070] Terminal alkynes may be referred to as “1-alkynes.” For example, “heptyne” may include 1-heptyne (e.g., hep-1-yne), 2-heptyne (e.g., hep-2-yne), 3-heptyne (e.g., hep-3-yne), or combinations thereof. Terminal alkynes may be straight-chain terminal alkynes (e.g., 1-butyne) or branched (e.g., bulky) terminal alkynes containing branched terminal alkynes (e.g., 4-methyl-1-pentyne) or cycloalkane terminal alkynes (e.g., cyclopropylacetylene).
[0071] Terminal alkynes may contain two or more triple bonds, one or more double bonds, or combinations thereof. When a terminal alkyne contains at least one triple bond and at least one double bond, the compound may be called an "enyne". Several enynes are provided herein, such as but-1-en-3-yne. The double bonds in an enyne may be terminal or non-terminal. When a terminal alkyne contains two triple bonds, the compound may be called a "diyne". A diyne may contain two terminal triple bonds, or one terminal triple bond and one non-terminal triple bond.
[0072] Terminal alkynes may contain heteroatoms, such as oxygen and nitrogen. When a terminal alkyne contains oxygen as a heteroatom, oxygen may exist as part of the ether moiety.
[0073] In some embodiments, the compound may include hexyne, heptyne, octyne, or combinations thereof. The term "heptyne" refers to a straight-chain compound comprising at least one triple bond and seven carbon atoms, wherein at least two of the seven carbon atoms are bonded together by triple bonds, and includes substituted derivatives thereof. The term "octyne" refers to a straight-chain compound comprising at least one triple bond and eight carbon atoms, wherein at least two of the eight carbon atoms are bonded together by triple bonds, and includes substituted derivatives thereof. Substituted derivatives of heptyne and octyne include, but are not limited to, C1-C2 substituted heptyne or C1-C2 substituted octyne. For example, the table below shows general schematic diagrams of embodiments of a seven-carbon straight-chain heptyne and embodiments of a C1-substituted heptyne.
[0074] In some embodiments, heptyne includes 2-heptyne, 3-heptyne, or combinations thereof. As used herein, the terms “2-heptyne” and “3-heptyne” refer to a heptyne in which the (i) second and third carbon atoms, or (ii) the third and fourth carbon atoms, are respectively bonded together by triple bonds. In some embodiments, octyne includes 3-octyne, 4-octyne, or combinations thereof. As used herein, the terms “3-octyne” and “4-octyne” refer to an octyne in which the (i) third and fourth carbon atoms, or (ii) the fourth and fifth carbon atoms, are respectively bonded together by triple bonds.
[0075] In some embodiments, the terminal alkyne includes compounds of formula (I): Where n is an integer selected from 0 to 5 or 0 to 4; and where R 1 Selected from hydrogen, C1-C6 alkyl groups, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc. Alternatively, R 1 Optional from C3-C 12 cycloalkyl, C3-C 10 Cycloalkyl or C3-C7 cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, etc.
[0076] In some embodiments, the terminal alkyne includes compounds of formula (II): Where n is an integer selected from 0 to 5 or 0 to 4; where m is an integer selected from 0 to 5 or 0 to 4; and where R 2 It is selected from hydrogen or C1-C6 alkyl, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc.
[0077] In some embodiments, the terminal alkyne includes compounds of formula (III): Where n is an integer selected from 0 to 5 or 0 to 4.
[0078] In some embodiments, the terminal alkyne includes compounds of formula (IV): Where n is an integer selected from 0 to 5 or 0 to 4; and where m is an integer selected from 0 to 5 or 0 to 4.
[0079] In some embodiments, the terminal alkyne includes compounds of formula (V): Where n is an integer selected from 0 to 5, 0 to 4, or 1 to 4.
[0080] In some embodiments, the terminal alkyne includes compounds of formula (VI): Where n is an integer selected from 0 to 5 or 0 to 4; and where R 3 It is hydrogen or C1-C6 alkyl, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc.
[0081] In some embodiments, the terminal alkyne includes compounds of formula (VII): Where n is an integer selected from 0 to 5 or 0 to 4; and where R 4 It is hydrogen or C1-C6 alkyl, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc.
[0082] In some implementations, alkynes, such as flavoring agents or terminal alkynes (when R... 5 Or R 6 When hydrogen is present, compounds of formula (VIII) are included: Where R 5 and R 6 Each can be independently hydrogen, C1-C6 alkyl, or C1-C6 cycloalkyl. C1-C6 can include methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc.
[0083] In some embodiments, heptyne and / or octyne include compounds of formula (IX): Where m is 2 or 3; n is 0 or 1; and m + n = 3 or 4 (for example, for heptynes m + n = 3 and for octynes m + n = 4).
[0084] In some embodiments, heptyne and / or octyne include compound (X): Where m is 1 or 2; n is 0 or 1; and m + n = 2 or 3 (for example, for heptynethyn m + n = 2 and for octyyn m + n = 3).
[0085] In some embodiments, heptyne and / or octyne include compounds of formula (XI): Where m is 1 or 2; n is 0 or 1; and m + n = 2 or 3 (for example, for heptynethyn m + n = 2 and for octyyn m + n = 3).
[0086] In some embodiments, terminal alkynes, terminal olefins, or non-terminal alkynes (e.g., when R...) 5 Or R 6 When hydrogen is present, compounds of formula (VIII) include any one or more of the following compounds:
[0087] Inhibitor / Flavoring Composition This document also provides compositions that may be compositions comprising compounds acting as hydrogen embrittlement inhibitors, flavorings, or combinations thereof. In some embodiments, the composition may comprise a compound that acts as both an embrittlement inhibitor and a flavoring. In alternative embodiments, the composition may comprise a compound acting as an embrittlement inhibitor and a compound acting as a flavoring (different from the embrittlement inhibitor). In some embodiments, the embrittlement inhibitor and the flavoring may be the same compound. In other embodiments, the embrittlement inhibitor and the flavoring may be different compounds. In some embodiments, the composition comprises any one or more compounds provided herein and an additive. The additive may be dispersed in the compound, or the compound may be dispersed in the additive, depending on whether the additive or the compound is the main component.
[0088] The additives in the compositions provided herein may include stabilizers, antioxidants, free radical inhibitors, or combinations thereof. In some embodiments, the additives are capable of reacting with flavoring toxins (e.g., oxygen (O2), ozone, superoxide anions (O2) - Organic peroxides (ROOR'), organic peroxy radicals (ROO•), organic hydroperoxides (ROOH), hydroxyl radicals (RO•), inorganic peroxides, hydrogen peroxide, metal oxides, and peroxynitroso (ONOO) -Additives can prevent or reduce the following: (i) formation of one or more undesirable products, (ii) flavoring polymerization, (iii) flavoring decomposition, or (iv) combinations thereof. Additives (e.g., free radical inhibitors) may be more reactive to flavoring toxins than to the flavoring itself. For example, phenolic derivatives exhibit antioxidant properties through two key mechanisms. In hydrogen atom transfer (HAT), phenolic antioxidants donate hydrogen atoms to free radicals, thereby neutralizing them and preventing oxidative damage to alkynes. This process stabilizes free radicals by converting them into less reactive substances. In single electron transfer (SET), phenolic compounds transfer an electron to a free radical, thereby reducing the free radical and preventing oxidative chain reactions. This helps reduce the autocatalytic nature of alkyne oxidation. Amine derivatives primarily act as antioxidants by neutralizing free radicals, which are highly reactive molecules that can cause oxidative damage to alkynes through three key mechanisms. Amines, especially aromatic amines, are effective at scavenging free radicals. They donate hydrogen atoms to free radicals, thereby neutralizing them and preventing further oxidation. Some amines can also break down hydroperoxides, intermediates in the oxidation process. This helps to decompose potentially harmful compounds before they damage alkynes. Hindered amines, such as those derived from 2,2,6,6-tetramethylpiperidine, are particularly effective in protecting materials from UV photodegradation. They work by neutralizing free radicals formed during UV irradiation. Organic acids, such as citric acid, malic acid, and tartaric acid, act as antioxidants, protecting organic compounds from oxidation through two key mechanisms. Organic acids neutralize free radicals, which are unstable molecules that cause oxidative damage to organic compounds. By donating electrons to these free radicals, organic acids stabilize them and prevent them from causing further damage to alkynes. Some organic acids can bind to metal ion impurities such as iron and copper, thereby catalyzing oxidation reactions. This reduces the availability of metal ions to participate in the oxidation reaction, thus protecting other organic compounds such as alkynes. Other compounds undergo chemical transformations, such as isopropanol, which can react with oxides to form acetone, thereby preventing the oxidation of the alkyne moiety. Other mechanisms and properties of additives are envisioned. This could include, for example, reactions between flavoring agents and flavoring toxins, catalyzed by equipment surfaces, such as storage tanks (e.g., metal or alloy surfaces and corresponding oxide surfaces), seals (e.g., organic elastomers), and plastic components (e.g., resins or processing additives contained in plastic components).
[0089] Additives can improve the stability of flavorings, such as any flavoring described herein. For example, the flavoring compositions or flavoring fluids provided herein can (i) be stored for at least 1 month, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 42 months, 48 months, 54 months, or 60 months; (ii) be stored at temperatures of at least -40°C, at least -30°C, at least -20°C, at least -10°C, at least 0°C, at least 10°C, at least 15°C, at least 20°C, at least 25°C, at least 35°C, at least 45°C, at least 50°C, at least 55°C, at least 60°C, at least 65°C, at least 70°C, at least 75°C, at least 80°C, at least 85°C, or at least 90°C; or (iii) combinations thereof, and during storage of the flavoring composition or flavoring fluid, less than 10 mol%, less than 5 mol%, less than 1 mol%, or less than 0.1 mol% of the flavoring polymerizes. As another example, the flavoring composition or flavoring fluid provided herein may (i) be stored for at least 1 month, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 42 months, 48 months, 54 months, or 60 months; (ii) be stored at the following temperatures: at least -40°C, at least -30°C, at least -20°C, at least -10°C, at least 0°C, at least 10°C, at least 15°C, at least 20°C, at least 25°C, at least 35°C, at least 45°C, at least 50°C, at least 55°C, at least 60°C, at least 65°C, at least 70°C, at least 75°C, at least 80°C, at least 85°C, or at least 90°C; or (iii) combinations thereof, and during the storage of the flavoring composition or flavoring fluid, less than 10 mol%, less than 5 mol%, less than 1 mol%, or less than 0.1 mol% of the flavoring agent is in contact with oxygen, ozone, peroxide, hydroxyl groups, hydroxyl radicals, metal oxides, or superoxide anions (O2). - The reaction forms oxygen-containing products.
[0090] Additives can be odorless or odorous compounds. Examples of odorous additives include, but are not limited to, cyclobutanol, 2,4-dimethylpentan-3-one, 2-methyl-1-pentanol, 4-methyl-2-pentanol, isopropyl ether, 2,2-dimethylbutanol, and isoamyl alcohol. alcohol / isopentanol), 2-methyl-1-butanol, (S)-(+)-4-methyl-2-pentanol, (2R)-2,3-dimethylbut-1-ol, (2R)-2-methylpentanol, 2,3-dimethylbut-1-ol, 3-methylhexane-2-ol, 2,3-dimethyl-2-pentanol, 3-methylpentanol, 2-methylpentanol, 3-methyl-(R)-3-hexanol, 3-pentanol, 2-methylpentanol, 2,3-dimethylbut-2-ol, 3-methyl-3-hexanol, 2,4-dimethyl-3-pentanol, 2-pentanol, 3-ethyl-2-pentanol Alcohols, 4,4-dimethylpentan-2-ol, 4-methylhexane-3-ol, 2-methylhexane-3-ol, 3-hexanol, 3,3-dimethyl-1-butanol, 2,4-dimethylpentan-2-ol, 2-methylhexane-2-ol, isopropanol, 2-methyl-(3S)-3-pentanol, propanol, 1-butanol, 1-pentanol, 2-methyl-2-butanol, 2-methyl-1-propanol (isobutanol), 2-butanol, (2R)-4,4-dimethylpentan-2-ol, 2-methyltetrahydrofuran, cis-2-penten-1-ol, 1-hexen-3-ol, 3-methyl-2-buten-1-ol, 3-buten-2-ol, 3-(1-methylethyl) 1-Propylene, 1-Penten-3-ol, 2-Ethyl-5-methylfuran, 2-Ethylfuran, 2-Methylfuran, Acetal, Butyl ether, Methyl tert-butyl ether, 1,1-Dimethoxyethane, 1-Methoxycyclohexene, 4-Methoxy-2-methyl-1-butene, 3-Methoxy-1-propenyl, Pentanal, Cyclobutanone, 2-Methylpentanal, Propanal, Butyraldehyde, 2,2-Dimethylpentanal, 3-Methylpentanal, ( 3S)-3-methylpentanal, 2-ethylpentanal, 2-methyl-(R)-pentanal, 3-methylbutanal (isopentanal), hexanal (n-hexanal), 2-methylpropanal (isobutanal), (2S)-2-methylpentanal, 2-ethylbutanal, butyl formate, cyclopentyl formate, 3-methyl-2-butenal, tetraldehyde, trans-2-butenal, 2-pentenal, 4-pentenal, (4E)-4-hexenal, 3-hexenal, hexenal, 4-methyl-2-pentenal, 2-methyl-2-pentenal, (2E)-2-hexenal, (3Z)-3-hexenal, 1-butene, 2,4,4-trimethyl-1-pentene, 2,4,4-Trimethyl-2-pentene, 1-pentene, 1-octene, 2-octene, 1-nonene, (E)-2-octene, 1,3-pentadiene, 2,3-dimethyl-1,3-butadiene, 2,3,4-trimethyl-2-pentene, 1-hexene, 1,5-hexadiene, 1,4-hexadiene, 3-methyl-1,2-butadiene, 1,5-hexadien-3-ol, cyclohexene, cyclopentene, 5-ethylidene-2-norbornene, ethyl propionate, ethyl butyrate, propyl butyrate, propyl propionate, methyl hexanoate (methyl hexanoate / methyl (caproate), ethyl isovalerate, methyl 3-methylvalerate, ethyl neovalerate, ethyl valerate, isobutyl propionate, tert-butyl acetate, methyl isobutyrate (methyl 2-methylpropionate), methyl propionate, methyl isovalerate, butyl propionate, methyl butyrate, methyl valerate, isopropyl propionate, isopropyl butyrate, propyl-2-yl, (2S)-2-methylbutyrate, ethyl 2-methylbutyrate, methyl 2-methylbutyrate, ethyl isobutyrate, isobutyl isobutyrate, butyl-2-propionate, isopropyl isobutyrate, Vinyl propionate, isobutyl acrylate, n-butyl acrylate, 4-pentenyl acetate, allyl propionate, methyl 3-butenoate, methyl methacrylate, ethyl methacrylate, (E)-2-butenoate, 4-methylhexane-2-one, 2-pentanone, 5-methyl-2-hexanone (methyl isopentyl ketone), 2-heptanone (methyl n-pentyl ketone), 4-heptanone, 3-methylhexane-2-one, 2,2-dimethyl-3-hexanone, 3-methyl-2-butanone, 2,2-dimethyl-3-pentanone, 3-hexanone, 4,4-Dimethyl-2-pentanone, 2-hexanone, 3-ethyl-2-pentanone, 5-methylhex-3-one, 2-methyl-3-hexanone, 2-butanone, 3-pentanone, sec-butyl acetate, isopropyl acetate, sec-amyl acetate, 1-methoxy-2-propyl acetate, propyl acetate, isobutyl acetate, butyl acetate, isopentyl acetate (isopentyl acetate / isoamyl) acetate), ethyl acetate, methyl butyl acetate, (2S)-2-methyl butyl acetate, isopropyl acetate, mesitylene oxide, 1-penten-3-one (vinyl ethyl ketone), 1-hexen-3-one (vinyl propyl ketone), 2-hexen-4-one, 1-hepten-3-one (vinyl butyl ketone), 4-methyl-4-penten-2-one, 3-methyl-3-penten-2-one, 3-penten-2-one, 2-methylphenol (o-cresol), 3-methylphenol (m-cresol), 4-methylphenol (p-cresol), 2-ethylphenol, 3-ethylphenol, 4-ethylphenol, 2- Propylphenol, 3-propylphenol, 4-propylphenol, 2-butylphenol, 3-butylphenol, 4-butylphenol, 2-methoxyphenol (guaiacol), 3-methoxyphenol, 4-methoxyphenol or 4-hydroxyanisole or hydroquinone monomethyl ether (also known as MeHQ), 2-ethoxyphenol, 3-ethoxyphenol, 4-ethoxyphenol, 2-methoxy-3-methylphenol, 4-methoxy-3-methylphenol, 2-methoxy-4-methylphenol (cresol), 3-methoxy-4-methylphenol, 2-methoxy-5-methylphenol (isocresol), 3-methoxy-5-methylphenol, 2-hydroxy Benzyl benzoic acid or salicylic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, methyl 2-hydroxybenzoate or methyl salicylate or wintergreen oil, methyl 3-hydroxybenzoate, methyl 4-hydroxybenzoate, ethyl 2-hydroxybenzoate or ethyl salicylate, ethyl 3-hydroxybenzoate, ethyl 4-hydroxybenzoate, 2,3-dimethylphenol, 2,4-dimethylphenol, 2,5-dimethylphenol, 2,6-dimethylphenol, 3,4-dimethylphenol, 3,5-dimethylphenol, 2-chlorophenol, 3-chlorophenol, 4-chlorophenol, 2-fluorophenol, 3-fluorophenol, 4-fluorophenol, 2-(trifluoromethyl)benzene Phenol, 3-(trifluoromethyl)phenol, 4-(trifluoromethyl)phenol, 2,4-dinitrophenol (DNP), 2,4-dinitro-6-sec-butylphenol (DNBP) and 2,6-dinitro-p-cresol, benzene-1,2-diol (catechol), benzene-1,3-diol (resorcinol), benzene-1,4-diol (hydroquinone, HQ), 3,4,5-trihydroxybenzoic acid or gallic acid, methyl 3,4,5-trihydroxybenzoate or methyl gallate, ethyl 3,4,5-trihydroxybenzoate or ethyl gallate, propyl 3,4,5-trihydroxybenzoate or propyl gallate, 3,4,Octyl 5-trihydroxybenzoate or octyl gallate, dimethyl hydroxylamine, trimethylamine, trimethylamine N-oxide, diethylamine, diethyl hydroxylamine, triethylamine, triethylamine N-oxide, dipropylamine, dipropyl hydroxylamine, tripropylamine, tripropylamine N-oxide, diisopropylamine, diisopropyl hydroxylamine, triisopropylamine, triisopropylamine N-oxide, dibutylamine, dibutyl hydroxylamine, tributylamine, tributylamine N-oxide, diisobutylamine, diisobutyl hydroxylamine Triisobutylamine, triisobutylamine N-oxide, di-tert-butylamine, di-tert-butylhydroxylamine, tri-tert-butylamine, tri-tert-butylamine N-oxide, diethylmethylamine, dipropylmethylamine, diisopropylmethylamine, dipropylethylamine, diisopropylethylamine, ethanolamine, diethanolamine, triethanolamine, N,N-dimethylisopropanolamine (DMPA), 2,2,6,6-tetramethylpiperidine, aniline, N,N-dimethylaniline, and N,N-diethylaniline.
[0091] Odorous additives can cause flavored fluids to emit warning odors. As a result, when the additive is odorous, the concentration of the flavoring agent used in the flavored fluid or flavoring composition can be reduced without adversely affecting the detectability of the flavored fluid.
[0092] Additives can generally be any compound capable of acting as a stabilizer, antioxidant, and / or free radical inhibitor, particularly for flavorings containing an alkynyl moiety. As used herein, the terms "stabilizer, antioxidant, and / or free radical inhibitor" refer to compounds or materials that prevent or delay the chemical degradation of fluid and / or flavoring compounds (such as alkynyls).
[0093] When the treated fluid compositions disclosed herein contain additives, and the additives comprise stabilizers, antioxidants, and / or free radical inhibitors, the additives may be present in the composition in any suitable amount. In some embodiments, based on the weight of the hydrogen embrittlement inhibitor in the composition (or based on the weight of the flavoring agent in the composition), the additives (stabilizers, antioxidants, and / or free radical inhibitors) are present in the composition at the following concentrations: about 10 ppmw (wt ppm) to about 10 wt%, about 10 ppmw to about 8 wt%, about 10 ppmw to about 6 wt%, about 10 ppmw to about 4 wt%, about 10 ppmw to about 2 wt%, about 10 ppmw to about 1 wt%, about 10 ppmw to about 5,000 ppmw, about 50 ppmw to about 10 wt%, about 50 ppmw to about 8 wt%, about 50 ppmw to about 6 wt%, about 50 ppmw to about 4 wt%, about 50 ppmw to about 2 wt%, about 50 ppmw to about 1 wt%, about 50 ppmw to about 5,000 ppmw, about 50 ppmw to about 1,000 ppmw, about 2 ... ppmw to about 10 wt%, about 200 ppmw to about 8 wt%, about 200 ppmw to about 6 wt%, about 200 ppmw to about 4 wt%, about 200 ppmw to about 2 wt%, about 200 ppmw to about 1 wt%, about 200 ppmw to about 5,000 ppmw, or about 200 ppmw to about 2,000 ppmw. More commonly, additives (stabilizers, antioxidants, and / or free radical inhibitors) are present in the composition at concentrations of: about 10 ppmw (wt ppm) to about 1,000 ppmw, about 10 ppmw to about 900 ppmw, about 10 ppmw to about 750 ppmw, about 10 ppmw to about 500 ppmw, about 50 ppmw to about 1,000 ppmw, about 50 ppmw to about 750 ppmw, about 50 ppmw to about 500 ppmw, about 200 ppmw to about 1,000 ppmw, about 200 ppmw to about 900 ppmw, about 200 ppmw to about 750 ppmw, or about 200 ppmw to about 500 ppmw.
[0094] Examples of stabilizers, antioxidants, and free radical inhibitors include phenolic derivatives, including but not limited to 2-methylphenol (o-cresol), 3-methylphenol (m-cresol), 4-methylphenol (p-cresol), 2-ethylphenol, 3-ethylphenol, 4-ethylphenol, 2-propylphenol, 3-propylphenol, 4-propylphenol, 2-butylphenol, 3-butylphenol, 4-butylphenol, 2-methoxyphenol (guaiacol), 3-methoxyphenol, 4-methoxyphenol or 4-hydroxyanisole or hydroquinone monomethyl ether (also known as MeHQ), 2-ethoxyphenol, 3-ethoxyphenol, 4-ethoxyphenol, 2-methoxy-3-methylphenol, 4-methoxy-3-methylphenol, 2-methoxy-4-methylphenol (methylphenol). Phenol), 3-methoxy-4-methylphenol, 2-methoxy-5-methylphenol (isocresol), 3-methoxy-5-methylphenol, 2,6-di-tert-butyl-4-methylphenol or butylhydroxytoluene or tert-butylhydroxytoluene (also known as BHT), a mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol, (1,1-dimethylethyl)-4-methoxyphenol or butylhydroxyanisole or tert-butylhydroxyanisole (also known as BOA or BHA), 2,5-di-tert-butylphenol, 2,6-di-tert-butylphenol, 2-(1,1-dimethylethyl)-1,4-benzenediol or mono-tert-butylhydroquinone or tert-butylhydroquinone (also known as MTBHQ or TBHQ), 2-hydroxybenzoic acid or water Salicylic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, methyl 2-hydroxybenzoate or methyl salicylate or wintergreen oil, methyl 3-hydroxybenzoate, methyl 4-hydroxybenzoate, ethyl 2-hydroxybenzoate or ethyl salicylate, ethyl 3-hydroxybenzoate, ethyl 4-hydroxybenzoate, 2,3-dimethylphenol, 2,4-dimethylphenol, 2,5-dimethylphenol, 2,6-dimethylphenol, 3,4-dimethylphenol, 3,5-dimethylphenol, 2,3,5-trimethylphenol, 2,3,6-trimethylphenol, 2,4,5-trimethylphenol, 2,4,6-trimethylphenol, 3,4,5-trimethylphenol, 2-chlorophenol, 3-chlorophenol, 4-chlorophenol, 2-fluorophenol, 3-fluorophenol, 4-fluorophenol Phenol, 2-(trifluoromethyl)phenol, 3-(trifluoromethyl)phenol, 4-(trifluoromethyl)phenol, 2,4-dinitrophenol (DNP), 2,4-dinitro-6-sec-butylphenol (DNBP), and 2,6-dinitro-p-cresol, catechol derivatives, including but not limited to benzene-1,2-diol (catechol), benzene-1,3-diol (resorcinol), benzene-1,4-diol (hydroquinone, HQ), 4-tert-butylcatechol (TBC), 2,5-bis(1,1-dimethylethyl)-1,4-benzenediol or 2,5-di-tert-butylhydroquinone (also known as DBHQ or DTBHQ), 2-methyl-1,4-benzenediol or toluene hydroquinone or methyl hydroquinone (also known as THQ or M-HQ), 3,4-5-Trihydroxybenzoic acid or gallic acid, methyl 3,4,5-trihydroxybenzoate or methyl gallate, ethyl 3,4,5-trihydroxybenzoate or ethyl gallate, propyl 3,4,5-trihydroxybenzoate or propyl gallate, and octyl 3,4,5-trihydroxybenzoate or octyl gallate, amine derivatives, including but not limited to dimethylhydroxylamine, trimethylamine, trimethylamine N-oxide, diethylamine, diethylhydroxylamine, triethylamine, and triethylamine N-oxide. Compounds, dipropylamine, dipropylhydroxylamine, tripropylamine, tripropylamine N-oxide, diisopropylamine, diisopropylhydroxylamine, triisopropylamine, triisopropylamine N-oxide, dibutylamine, dibutylhydroxylamine, tributylamine, tributylamine N-oxide, diisobutylamine, diisobutylhydroxylamine, triisobutylamine, triisobutylamine N-oxide, di-tert-butylamine, di-tert-butylhydroxylamine, tri-tert-butylamine, tri-tert-butylamine N-oxide, diethylmethylamine, dipropylmethylamine, diisopropylmethylamine, dipropyl... Ethylamine, diisopropylethylamine, ethanolamine, diethanolamine, triethanolamine, N,N-dimethylisopropanolamine (DMPA), 2,2,6,6-tetramethylpiperidine, 2,2,6,6-tetramethylpiperidine N-oxide (TEMPO) and its derivatives, pyridine N-oxide, N-methylmorpholine N-oxide (NMMO), lauryl dimethylamine N-oxide, N,N-dimethyldodecylamine N-oxide, N,N-dimethyloctylamine N-oxide, N,N-dimethylhexadecylamine N-oxide, N-palmitoylethanolamine (PEA), N-acetylethanolamine (AEA), N-myristoylethanolamine (MEA), diphenylamine, phenyl-α-naphthylamine (PANA), N,N'-di-2-butyl-1,4-phenylenediamine (DBPDA), N,N-dibenzylhydroxylamine (DBHA), 1,4-phenylenediamine, aniline, N,N-dimethylaniline and N,N-Diethylaniline, organic acids, including but not limited to formic acid, acetic acid, benzoic acid, sorbic acid, citric acid, malic acid, tartaric acid, succinic acid, lactic acid, and oxalic acid; inorganic acids and salts, including but not limited to hypophosphite, sodium metabisulfite, sodium bisulfite, sodium sulfite, sodium nitrite, sodium thiosulfate, sodium selenite, sodium hypophosphite, sodium selenate, sodium selenite, sodium hypochlorite, sodium persulfate, and equivalent potassium salts; natural product derivatives, including but not limited to ascorbic acid (vitamin C) or its derivatives (e.g., ascorbyl palmitate, ascorbyl acetate, etc.), tocopherols and tocotrienols (vitamin E) or their derivatives (e.g., α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol, tocopheryl acetate, etc.); retinol (vitamin A) or its derivatives (e.g., retinoic acid, retinyl alcohol, etc.). Retinyl palmitate, etc.), hydroxycinnamate or its derivatives (e.g., caffeic acid, chlorogenic acid, ferulic acid, p-coumaric acid, etc.), flavonoids or their derivatives (taxanthin, luteolin, apigenin, hesperidin, quercetin, kaempferol, myricetin, fisetin, galangin, isorhamnetin, styraxol, rhamnoside, pyranoflavone alcohol, furanoflavonol, hesperidin, naringin, styraxol, styraxol, anthocyanins, delphinidin, malvain, pelargonidin, paeoniflorin, petunidin, catechin, gallocatechin, catechin-3-gallate, gallocatechin-3-gallate, epicatechin, epigallocatechin, epigallocatechin, epigallocatechin-3-gallate, epigallocatechin-3-gallate, etc.), glutathione, melatonin and uric acid. ,
[0095] In some embodiments, the boiling point of the additive is about 300°C or lower, about 270°C or lower, about 250°C or lower, about 220°C or lower, about 190°C or lower, about 160°C or lower, about 130°C or lower, about 120°C or lower, about 110°C or lower, or about 100°C or lower. In some embodiments, the freezing point of the additive is about 100°C or lower, about 50°C or lower, about 0°C or lower, about -80°C or lower, about -70°C or lower, about -60°C or lower, about -50°C or lower, about -40°C or lower, about -30°C or lower, about -20°C or lower, or about -10°C or lower.
[0096] The additive may be a non-toxic compound. The additive may also be environmentally friendly. In some embodiments, the acute oral toxicity of the additive is at least 100 mg / kg, at least 200 mg / kg, at least 300 mg / kg, at least 500 mg / kg, at least 1,000 mg / kg, at least 2,000 mg / kg, at least 3,000 mg / kg, at least 4,000 mg / kg, or at least 5,000 mg / kg.
[0097] The additive may be of any volatility. The additive may be relatively volatile. In some embodiments, the vapor pressure of the additive (at 20°C) is at least 0.001 kPa, at least 0.01 kPa, at least 0.1 kPa, or at least 1 kPa.
[0098] The additive may be a compound containing an aldehyde moiety, such as those selected from: acetaldehyde, propionaldehyde, 1-butyraldehyde, isobutyraldehyde (2-methylpropionaldehyde), pentanal / valeraldehyde, isopentanal (isovaleraldehyde or 3-methylbutyraldehyde), 2-methylbutyraldehyde, neopentanal (2,2-dimethylpropionaldehyde), hexanal, 4-methylpentanal, 3-methylpentanal, 2-methylpentanal, 3,3-dimethylbutyraldehyde, 1-octanal, furfural, glyoxal, or combinations thereof. In some embodiments, the additive is C3-C 10 Alkyl aldehydes, C3-C6 alkyl aldehydes or their derivatives, such as derivatives comprising an alkenyl moiety, an alkynyl moiety or a combination thereof, wherein the alkyl aldehyde is a cyclic or acyclic aldehyde.
[0099] The additive may be a compound containing a ketone moiety (e.g., one ketone moiety, two ketone moiety, three ketone moiety, etc.). For example, the additive may include compounds selected from: acetone, butanone, 2-pentanone, 3-pentanone, 3-methyl-2-butanone, 2-hexanone, 3-hexanone, 3-methyl-2-pentanone, 2-methyl-3-pentanone, 4-methylpentanone, 3,3-dimethyl-2-butanone, 2,3-butanedione, 2,3-pentanedione, 2,4-pentanedione, 3-methyl-pentane-2,4-dione, cyclobutanone, cyclopentanone, cyclohexanone, methyl isobutyl ketone, or combinations thereof. In some embodiments, the compound is C3-C 10 Alkyl ketones, C3-C 10 Alkyl diketones, C4-C8 alkyl ketones, C4-C8 alkyl diketones, C3-C6 alkyl ketones, C3-C6 alkyl diketones or derivatives thereof, such as derivatives comprising an alkenyl moiety, an alkynyl moiety or a combination thereof, wherein the alkyl ketone is a cyclic alkyl ketone or an acyclic alkyl ketone.
[0100] The additive may be a compound comprising an alcohol moiety (e.g., one alcohol moiety, two alcohol moiety, etc.). For example, the additive may include a compound selected from methanol, ethanol, propanol, isopropanol, butanol, 2-butanol, tert-butanol, 3-methyl-2-butanol, 2-pentanol, 3-pentanol, 2-methyl-3-pentanol, butane-2,3-diol, 1-octanol, 2,3-pentanediol, 2,4-pentanediol, benzyl alcohol, or combinations thereof. In some embodiments, the additive comprises C1-C... 10 Alkyl alcohols, C1-C 10 Alkyl glycols, C2-C 10Alkyl alcohols, C2-C 10 Alkyl glycols, C1-C6 alkyl alcohols, C1-C6 alkyl glycols or their derivatives, such as derivatives containing an alkenyl moiety, an alkynyl moiety or a combination thereof.
[0101] The additive may be a compound containing an ester moiety. For example, the additive may contain methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, isobutyl acetate, tert-butyl acetate, methyl propionate, ethyl propionate, propyl propionate, isopropyl propionate, methyl sorbate, ethyl sorbate, propyl sorbate, isopropyl sorbate, ethyl 2-butynedate, or combinations thereof. In some embodiments, the compound is C2 to C3. 10 Alkyl esters, C2-C6 alkyl esters or derivatives thereof, such as derivatives comprising an alkenyl moiety, an alkynyl moiety or a combination thereof.
[0102] The additive may be a compound containing an ether moiety. For example, the additive may contain dimethyl ether, diethyl ether, methyl ethyl ether, dipropyl ether, methyl propyl ether, etherpropyl ether, diisopropyl ether, methyl isopropyl ether, ethyl isopropyl ether, propyl isopropyl ether, methyl butyl ether, ethyl butyl ether, methyl isobutyl ether, ethyl isobutyl ether, or combinations thereof. In some embodiments, the additive contains C1-C... 10 Dialkyl ethers, C1-C6 dialkyl ethers, C1-C2 dialkyl ethers or derivatives thereof, such as derivatives comprising an alkenyl moiety, an alkynyl moiety or a combination thereof.
[0103] The additive can be an unsubstituted or substituted diphenyl ether, or an unsubstituted or substituted C1-C ether. 10 Alkylphenyl ethers (which may have the following structures: C1-C) 10 Alkyl-O-Ph, wherein optionally the phenyl moiety is substituted.
[0104] In some embodiments, the additive is a compound comprising a cycloalkanol moiety, such as a compound selected from cyclopropanol, cyclobutanol, cyclopentanol, or combinations thereof. In some embodiments, the additive is a C3-C8 cycloalkanol or a C3-C4 cycloalkanol.
[0105] In some embodiments, the additive is an unsubstituted or substituted phenol, such as 2-methylphenol (o-cresol), 3-methylphenol (m-cresol), 4-methylphenol (p-cresol), 2-ethylphenol, 3-ethylphenol, 4-ethylphenol, 2-propylphenol, 3-propylphenol, 4-propylphenol, 2-butylphenol, 3-butylphenol, 4-butylphenol, 2-methoxyphenol (guaiacol), 3-methoxyphenol, 4-methoxyphenol or 4-hydroxyanisole or hydroquinone monomethyl ether (also known as MeHQ), 2-ethoxyphenol, 3-ethoxyphenol, 4-ethoxyphenol, 2-methoxy-3-methylphenol, 4-methoxy-3-methylphenol, 2-methoxy-4-methylphenol (cresol), 3- Methoxy-4-methylphenol, 2-methoxy-5-methylphenol (isocresol), 3-methoxy-5-methylphenol, 2,6-di-tert-butyl-4-methylphenol or butylhydroxytoluene or tert-butylhydroxytoluene (also known as BHT), a mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol, (1,1-dimethylethyl)-4-methoxyphenol or butylhydroxyanisole or tert-butylhydroxyanisole (also known as BOA or BHA), 2,5-di-tert-butylphenol, 2,6-di-tert-butylphenol, 2-(1,1-dimethylethyl)-1,4-benzenediol or mono-tert-butylhydroquinone or tert-butylhydroquinone (also known as MTBHQ or TBHQ), 2-hydroxybenzoic acid or salicylic acid, 3-Hydroxybenzoic acid, 4-hydroxybenzoic acid, methyl 2-hydroxybenzoate or methyl salicylate or wintergreen oil, methyl 3-hydroxybenzoate, methyl 4-hydroxybenzoate, ethyl 2-hydroxybenzoate or ethyl salicylate, ethyl 3-hydroxybenzoate, ethyl 4-hydroxybenzoate, 2,6-dimethylphenol, 3,4-dimethylphenol, 3,5-dimethylphenol, 2,3,5-trimethylphenol, 2,3,6-trimethylphenol, 2,4,5-trimethylphenol, 2,4,6-trimethylphenol, 3,4,5-trimethylphenol, 2-chlorophenol, 3-chlorophenol, 4-chlorophenol, 2-fluorophenol, 3-fluorophenol, 4-fluorophenol, 2-(trifluoromethyl)phenol, 3-(trifluoromethyl)phenol, 4-(trifluoromethyl)phenol 2,4-Dinitrophenol (DNP), 2,4-dinitro-6-sec-butylphenol (DNBP) and 2,6-dinitro-p-cresol, benzene-1,2-diol (catechol), benzene-1,3-diol (resorcinol), benzene-1,4-diol (hydroquinone, HQ), 4-tert-butylcatechol (TBC), 2,5-bis(1,1-dimethylethyl)-1,4-benzenediol or 2,5-di-tert-butylhydroquinone (also known as DBHQ or DTBHQ), 2-methyl-1,4-benzenediol or toluene-hydroquinone or methylhydroquinone (also known as THQ or M-HQ), 3,4,5-trihydroxybenzoic acid or gallic acid, methyl 3,4,5-trihydroxybenzoate or methyl gallate, 3,4,Ethyl 5-trihydroxybenzoate or ethyl gallate, propyl 3,4,5-trihydroxybenzoate or propyl gallate, and octyl 3,4,5-trihydroxybenzoate or octyl gallate, or combinations thereof.
[0106] In some embodiments, the additive is a compound comprising a carboxylic acid moiety, such as compounds selected from formic acid, acetic acid, benzoic acid, sorbic acid, citric acid, malic acid, tartaric acid, succinic acid, lactic acid, oxalic acid, or combinations thereof. In some embodiments, the additive is C2-C. 10 Alkyl carboxylic acids or their derivatives, such as derivatives comprising an alkenyl moiety, an alkynyl moiety, or a combination thereof.
[0107] In some implementations, the additive is an unsubstituted or substituted quinoline.
[0108] Treated fluid compositions containing additives can be prepared in any suitable manner, but typically involve a method that involves contacting the fluid, hydrogen embrittlement inhibitor, additive, and optional flavoring agent in any order or sequence. It is important to avoid odor leakage or release during the preparation of the treated fluid compositions.
[0109] For example, in one embodiment, the treated fluid composition is prepared by a method comprising: introducing an additive in solid or liquid form into a flavoring container through a first sealed inlet; introducing the flavoring agent and a hydrogen embrittlement inhibitor into the flavoring container through a first or second sealed inlet and mixing them with the additive to form a flavoring composition; and discharging at least a portion of the flavoring composition from the flavoring container through a sealed outlet and contacting it with the fluid to form the treated fluid composition. Mixing can simply allow sufficient time for the materials to combine and form a homogeneous composition, or suitable stirring techniques can be used. The flavoring container can be any suitable storage tank, ISO tank container, Schmidt drum, etc.
[0110] In another embodiment, the treated fluid composition can be prepared by a method comprising: introducing an additive in liquid form into a multi-port container; connecting the multi-port container to a flavoring container containing a flavoring agent and a hydrogen embrittlement inhibitor, transferring the additive into the flavoring container through a sealed inlet, and mixing the additive with the flavoring agent and the hydrogen embrittlement inhibitor to form a flavoring composition; disconnecting the multi-port container from the flavoring container; and discharging at least a portion of the flavoring composition from the flavoring container through a sealed outlet and contacting it with the fluid to form the treated fluid composition. The transfer of the additive from the multi-port container to the flavoring container can be achieved by any suitable means, such as pumping, gravity-driven flow, pressure-driven flow, etc. If the additive is in solid form, a concentrated solution can be prepared by combining the solid additive with a small amount of flavoring agent or inhibitor and introducing a concentrated solution (in liquid form) into the multi-port container.
[0111] In other embodiments, the additive may contain a diluent, such as a diluent for compounds like alkynes or terminal olefins. The additive may contain C5-C8 saturated hydrocarbons (e.g., pentane, cyclopentane, hexane, cyclohexane, heptane, cycloheptane, octane) and / or fluorinated hydrocarbons, such as PFC-116, PFC-C216, PFC-218, or PFC-318.
[0112] Compounds, such as alkynes or terminal alkenes, can typically be present in the composition in any desired amount. In some embodiments, the compounds are present in the composition in amounts of at least 1 wt%, at least 5 wt%, at least 10 wt%, at least 20 wt%, at least 30 wt%, at least 40 wt%, at least 50 wt%, at least 60 wt%, at least 70 wt%, at least 80 wt%, or at least 90 wt%, based on the total weight of the composition. If two or more compounds are present, such as a first terminal alkyne and a second terminal alkyne, the first and second terminal alkynes can be present in the flavoring composition in a total amount of at least 10 wt%, at least 20 wt%, at least 30 wt%, at least 40 wt%, at least 50 wt%, at least 60 wt%, at least 70 wt%, at least 80 wt%, or at least 90 wt%, based on the total weight of the composition. For example, if 20 g of the first terminal alkyne and 30 g of the second terminal alkyne are present in a composition with a total weight of 100 g, the first and second alkynes are present in the flavoring composition in a total amount of 50 wt%.
[0113] The composition can typically be in any phase, such as liquid or gas. The composition can be stored and / or used in any desired phase.
[0114] Processed fluid composition This document also provides treated fluid compositions. The phrases “treated fluid composition” and “treated fluid” are used interchangeably herein. In some embodiments, the treated fluid typically comprises (i) a fluid, such as a gas, and (ii) any compound disclosed herein, such as terminal alkynes and terminal olefins. The compound or composition may be uniformly or non-uniformly dispersed in the fluid.
[0115] Compounds, such as terminal alkynes and terminal alkenes, may be present in the treated fluid in any desired amount. When the composition is present in the treated fluid, it may be present in an effective amount to achieve the desired concentration of the compound in the treated fluid. In some embodiments, the compound (e.g., a terminal alkyne or terminal olefin) is present in the treated fluid at a concentration of 1,000 mg / m³. 3 n or lower, 900 mg / m 3 n or lower, 800 mg / m 3 n or lower, 700 mg / m 3 n or lower, 600 mg / m 3 n or lower, 500 mg / m 3 n or lower, 400 mg / m 3 n or lower, 300 mg / m 3 n or lower, 200 mg / m 3 n or lower, 100 mg / m 3 n or lower, 90 mg / m 3 n or lower, 80 mg / m 3 n or lower, 70 mg / m 3 n or lower, 60mg / m 3 n or lower, 50 mg / m 3 n or lower, 40 mg / m 3 n or lower, 30 mg / m 3 n or lower, 20 mg / m 3 n or lower, or 10 mg / m³ 3 n or lower. In some embodiments, the compound (e.g., a terminal alkyne or a terminal olefin) is present in the treated fluid at a concentration of at least 0.1 mg / m³. 3 n, at least 0.5 mg / m 3 n, at least 1 mg / m 3 n, at least 2 mg / m 3 n, at least 3mg / m 3 n, at least 4 mg / m 3 n, at least 5 mg / m 3 n, at least 6 mg / m 3 n, at least 7 mg / m3 n, at least 8 mg / m 3 n, at least 9mg / m 3 n, or at least 10 mg / m 3 n. In some embodiments, the compound (e.g., a terminal alkyne or a terminal olefin) is present in the treated fluid at a concentration of approximately 1 mg / m³. 3 n to approximately 1,000 mg / m 3 n, approximately 1 mg / m 3 n to approximately 900 mg / m 3 n, approximately 1 mg / m 3 n to approximately 800 mg / m 3 n, approximately 1 mg / m 3 n to approximately 700 mg / m 3 n, approximately 1 mg / m 3 n to approximately 600 mg / m 3 n, approximately 1 mg / m 3 n to approximately 500 mg / m 3 n, approximately 1 mg / m 3 n to approximately 400 mg / m 3 n, approximately 1 mg / m 3 n to approximately 300 mg / m 3 n, approximately 1 mg / m 3 n to approximately 200 mg / m 3 n, approximately 1 mg / m 3 n to approximately 100 mg / m 3 n, approximately 1 mg / m 3 n to approximately 90 mg / m 3 n, approximately 1 mg / m 3 n to approximately 80 mg / m 3 n, approximately 1 mg / m 3 n to approximately 70 mg / m 3 n, approximately 1 mg / m 3 n to approximately 60 mg / m 3 n, approximately 1 mg / m 3 n to approximately 50 mg / m 3 n, approximately 1 mg / m 3 n to approximately 40 mg / m 3 n, approximately 1 mg / m 3 n to approximately 30 mg / m 3 n, approximately 1 mg / m 3 n to approximately 20 mg / m 3 n, or approximately 1 mg / m 3 n to approximately 10 mg / m 3n. In some embodiments, the compound (e.g., a terminal alkyne or a terminal olefin) is present in the treated fluid at a concentration of approximately 5 mg / m³. 3 n to approximately 8,000 mg / m 3 n, approximately 5 mg / m 3 n to approximately 5,000 mg / m 3 n, approximately 5 mg / m 3 n to approximately 2,500 mg / m 3 n, approximately 5 mg / m 3 n to approximately 1,000 mg / m 3 n, approximately 5 mg / m 3 n to approximately 900 mg / m 3 n, approximately 5 mg / m 3 n to approximately 800 mg / m 3 n, approximately 5 mg / m 3 n to approximately 700 mg / m 3 n, approximately 5 mg / m 3 n to approximately 600 mg / m 3 n, approximately 5 mg / m 3 n to approximately 500 mg / m 3 n, approximately 5 mg / m 3 n to approximately 400 mg / m 3 n, approximately 5 mg / m 3 n to approximately 300 mg / m 3 n, approximately 5 mg / m 3 n to approximately 200 mg / m 3 n, approximately 5 mg / m 3 n to approximately 100 mg / m 3 n, approximately 5 mg / m 3 n to approximately 90 mg / m 3 n, approximately 5 mg / m 3 n to approximately 80 mg / m 3 n, approximately 5 mg / m 3 n to approximately 70 mg / m 3 n, approximately 5 mg / m 3 n to approximately 60 mg / m 3 n, approximately 5 mg / m 3 n to approximately 50 mg / m 3 n, approximately 5 mg / m 3 n to approximately 40 mg / m 3 n, approximately 5 mg / m 3 n to approximately 30 mg / m 3 n, approximately 5 mg / m 3 n to approximately 20 mg / m3 n, or approximately 5 mg / m 3 n to approximately 10 mg / m 3 However, in other embodiments, the compound (e.g., a terminal alkyne or a terminal olefin) is present in the treated fluid at a concentration of approximately 1,000 mg / m³. 3 n to approximately 8,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 3,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 4,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 1,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 3,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 4,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 1,000 mg / m 3 n to approximately 5,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 5,000 mg / m 3 n, or approximately 3,000 mg / m 3 n to approximately 5,000 mg / m 3 n. As used in this article, "mg / m 3 The “n” in the figure indicates that the concentration was measured at “normal” atmospheric pressure (1 bar, 101.325 kPa, or 14.7 psi).
[0116] Depending on the properties of the fluid present in the treated fluid, the treated fluid can be a treated fluid suitable for a specific application. For example, as described herein, the treated fluid can be fuel for a fuel cell.
[0117] Methods of handling fluids This document also provides methods for treating fluids. In some embodiments, the methods include providing a fluid and contacting the fluid with a compound (e.g., a terminal alkyne or a terminal olefin) or a composition provided herein to form a treated fluid.
[0118] Before, during, or after performing any of the limitations provided herein, the fluid and / or treated fluid may be present in the fuel distribution system. The fuel distribution system may include any fuel supply infrastructure (e.g., fuel storage, fuel distribution, fuel delivery, etc.). In some embodiments, the method of treating the fluid further includes placing the fluid and / or treated fluid into the fuel distribution system, such as any fuel supply infrastructure (e.g., fuel storage, fuel distribution, fuel delivery, etc.).
[0119] Providing the fluid may include capturing the fluid. Any technique known in the art may be used to collect the fluid. In some embodiments, the method further includes pressurizing the treated fluid, storing the treated fluid, or a combination thereof. The compound or composition may be in any phase (e.g., liquid, gas, or a combination thereof) before, during, and / or after contact between the fluid and the compound (e.g., a terminal alkyne or olefin) or composition. Providing the fluid may include providing a container for holding the fluid, and contact between the fluid and the compound or composition may include placing the compound or composition in the container. Providing the fluid may include providing a first material stream containing the fluid. When providing the first material stream containing the fluid, contact between the fluid and the compound or composition may include contact between the first stream and a second material stream containing the compound or composition.
[0120] Contact between a fluid and a compound (e.g., a terminal alkyne or terminal olefin) or composition can be achieved using any known technique. For example, contact between a fluid and a compound or composition may include dispensing the compound or composition using a liquid meter. Alternatively, contact between a fluid and a compound or composition may include atomizing the compound or composition.
[0121] fluid The compounds (such as terminal alkynes and terminal olefins) or compositions provided herein can be used to treat any fluid, and the treated fluid may include any fluid. Fluids can generally be in any phase, such as liquid or gas. In some embodiments, the fluid contains fuel gas. The fluid may contain hydrogen (H2) or a mixture of hydrogen. The fluid may contain natural or synthetic combustion gases. The fluid may contain natural gas, liquefied natural gas (LNG), liquefied petroleum gas (LPG), municipal gas, town gas (16-20% carbon dioxide (CO2), 1-4% carbon monoxide (CO), 28-31% methane (CH4), 46-52% H2, nitrogen (N2), and 0-4% oxygen (O2)), heating gas, or combinations thereof. The fluid may contain H2, CH4, ethane (C2H6), ethylene (C2H4), acetylene (C2H2), propane (C3H8), propylene (C3H6), butane (C4H2), CH4, ethane (C2H6), ethylene (C2H4), acetylene (C2H2), propane (C3H8), propylene (C3H6), butane (C4H2), etc. 10 ), isobutane (C4H) 10 ), butene (C4H8), pentane (C5H) 12The fluid may contain water gas, syngas or syngas (30-60% CO, 25-30% H2, 0-5% CH4 and 5-15% CO2), reformer gas, producer gas, coke gas or combinations thereof. The fluid may contain non-flammable gases. The fluid may contain CO, CO2, industrial gases (e.g., nitrogen (N2), oxygen (O2) and / or helium) or combinations thereof. In a particular embodiment, the fluid contains hydrogen (H2), and at least 10 mol%, at least 20 mol%, at least 30 mol%, at least 50 mol%, at least 75 mol%, at least 85 mol%, at least 90 mol%, at least 95 mol%, at least 97 mol%, at least 98 mol%, or at least 99 mol% of the fluid is hydrogen. In another embodiment, the fluid contains hydrogen (H2), and 10 mol% to 40 mol%, 10 mol% to 30 mol%, 10 mol% to 25 mol%, 15 mol% to 30 mol%, or 15 mol% to 25 mol% of the fluid is hydrogen.
[0122] sensor The compounds (e.g., terminal alkynes or terminal olefins) or compositions provided herein may be used in combination with sensors (e.g., sensors for indicating the presence of flavoring compounds). Therefore, the systems provided herein comprise a sensor and a compound (e.g., a terminal alkyne or terminal olefin) as a flavoring agent, or comprise a sensor and a composition comprising a compound (e.g., a terminal alkyne or terminal olefin) as a flavoring agent.
[0123] The sensor can be coupled to any device or equipment, such as a pipe, fuel supply source, fuel cell, or some other component of a fuel cell system, or any appliance that uses hydrogen as fuel, or any component of an appliance that uses hydrogen as fuel. The sensor can be located near a self-sufficient fuel supply source, fuel consumption unit, or both, allowing the sensor to quickly and / or effectively detect any leaks. The sensor may also include circuitry programmed to shut down the fuel cell, other appliance or system, or any other component upon detecting a leak. Adding a sensor facilitates the use of extremely low concentrations of organic flavorings that are imperceptible to humans in specific applications or situations. Furthermore, the flavoring agent can be selected, which may be a terminal alkyne or a terminal olefin, enabling extremely high sensitivity and selectivity of the sensor to avoid false alarms.
[0124] Methods of generating energy This document also provides methods for generating energy. These methods typically include using any treated fluid provided herein as an energy source. The treated fluid can be used as fuel for appliances or devices such as fuel cells. In some embodiments, the method includes providing a fuel cell with an anode and contacting the anode with any treated fluid provided herein (e.g., treated hydrogen). Contact between the anode and the treated fluid produces an oxidized treated fluid.
[0125] Methods for generating energy may include providing a flavoring fluid, providing a fuel cell containing an anode, and contacting the anode with the flavoring fluid. Contacting the anode with the flavoring fluid can produce an oxidized flavoring fluid. In some embodiments, the method includes removing (e.g., washing, adsorbing, absorbing, or decomposing) compounds, such as terminal alkynes, terminal olefins, and / or additives, from the treated fluid or oxidized treated fluid. The removal of compounds may be performed at any one or more points in the methods provided herein. For example, the method may include removing compounds from an oxidized treated fluid or removing compounds from the treated fluid before contacting the anode with the treated fluid. In some cases, removing compounds from the fuel gas may be necessary or desirable, for example (i) when compounds such as terminal alkynes, terminal olefins, additives, etc., are harmful to the end use of the fuel gas or the fuel gas consuming appliance and / or device; and / or (ii) when compounds such as terminal alkynes, terminal olefins, additives, etc., are not eliminated during fuel gas consumption, which may result in the release of compounds into the environment, potentially negating the ability of the flavoring agent to indicate a leak.
[0126] In some embodiments, the method includes removing (e.g., scrubbing, adsorption, absorption, or decomposition) compounds, such as terminal alkynes, alkenes, additives, flavorings, etc., from exhaust gases, tail gases, or flue gases generated from fuel cells or any apparatus using hydrogen. The compounds described herein, such as terminal alkynes or alkenes, additives, flavorings, etc., can be removed by any known technique, such as (i) specially designed or commercially available adsorption or absorption processes, (ii) water traps, and / or (iii) humidifier systems based on the solubility of the compounds in water.
[0127] Removal (e.g., washing, adsorption, absorption, or decomposition) of compounds such as terminal alkynes, terminal olefins, and additives from treated and / or oxidized treated fluids can be achieved by any known technique. These techniques may include, but are not limited to, catalytic decomposition on metals, metal oxides, zeolites, or other matrices (see US7780933B2, US8658321B2, JP2018153634A, JP06317909B2, JP05766744B2, JP6306377A, JP04745557B2, US8444945B2, JP04822692B2, US7837964B2, US20080090115A1, US10889597B2); Absorption or adsorption on activated carbon, zeolite, silica, or other matrices (see JP07271867B2, JP05949333B2, JP2012143747A, JP2011201975A, JP05295689B2, JP2001019984A, JP2001157709A, US6875410B2, JP05051864B2, US805777B2, EP2337621B1); condensation; concentration; evaporation; filtration; membrane separation; or combinations thereof. In some embodiments, removing odorants may involve contacting the odorous fluid or waste gas with an adsorption and / or absorption medium or a membrane separation medium.
[0128] More specifically, compounds can be removed from fluids (such as treated or oxidized treated fluids) by using an adsorption or absorption medium of one or more materials (e.g., porous supports). Non-limiting examples of such materials include silica-alumina; silica; alumina; zeolites, preferably containing Ag, Cu, Zn, Ni, Fe, Ce, La, Zr and Ti metals, titanium dioxide, zirconium oxide, magnesium oxide, silica-magnesium oxide or zinc oxide zeolites; porous inorganic oxides, such as those selected from the group consisting of Ag, Cu, Ni, Zn, Mn, Fe, Co, Al, Si, Ce, alkali metals, alkaline earth metals or rare earth metals; kaolin; clay; diatomaceous earth; activated carbon; activated carbon oxides; activated carbon formed by treating activated carbon with nitric acid; organometallic framework compounds (MOFs); and granular, powdered and fibrous polymeric adsorbents.
[0129] By using one or more materials, such as porous inorganic oxides selected from the group consisting of Ag, Cu, Ni, Zn, Mn, Fe, Co, Al, Si, B, and P; alkali metals; alkaline earth metals (e.g., oxides of magnesium, calcium, strontium, and barium); rare earth metals (e.g., oxides of scandium, yttrium, cerium, ytterbium, and lanthanum); and transition metals (e.g., oxides of nickel, cobalt, vanadium, chromium, manganese, molybdenum, tungsten, copper, silver, zinc, iron, titanium, and zirconium), catalytic conversion into one or more compounds with a low odor detection threshold can remove the compounds from the treated fluid. Alternatively, the porous inorganic oxides may be selected from the group consisting of alumina, silica, silica-alumina, and cerium oxide; transition metal oxides; transition metal compounds; alkaline earth metal oxides; and rare earth metal oxides. Preferably, the transition metals are nickel, cobalt, vanadium, chromium, manganese, molybdenum, tungsten, copper, silver, zinc, iron, titanium, and / or zirconium. Preferably, the alkaline earth metals are magnesium, calcium, barium, and / or strontium. Preferably, the rare earth metal of the rare earth oxide is selected from scandium, yttrium, cerium, ytterbium, and / or lanthanum. Alternatively, the porous inorganic oxide may be selected from Group 13-14 oxides, wherein the Group 13-14 elements are selected from boron, aluminum, gallium, silicon, germanium, and / or tin. Alternatively, the following may be used to remove compounds from the treated fluid: noble metal catalysts, such as Pt / Pd / Rh catalysts, Pt / Pd catalysts, Pt / Rh catalysts, Pd / Rh catalysts, Pt catalysts, Pd catalysts, Au catalysts, Pt / Al2O3 catalysts; oxide catalysts, such as zeolites, silica-alumina, silica, alumina, zeolites, titanium dioxide, zirconium oxide, magnesium oxide, silica-magnesium oxide, zinc oxide; Cu-ZSM-5 catalysts; organometallic framework (MOF) catalysts; and particulate, powdered, or fibrous perovskite catalysts.
[0130] Alternatively, compounds can be removed from the treated fluid by washing in a water trap or solvent trap containing alkali metal hydroxides, alkali metal C1 to C4 alkyl acids, inorganic peroxides, organic peroxides, perchlorates, ionic or nonionic emulsifiers, or combinations thereof.
[0131] Removing at least a portion of the flavoring agent from the flavoring fluid or exhaust gas may include condensing the flavoring fluid or exhaust gas. Condensation may include cooling, pressurizing, or a combination thereof on the flavoring fluid or exhaust gas to recover at least a portion of the flavoring agent as a liquid.
[0132] Removing at least a portion of a flavoring agent from a flavored fluid or exhaust gas may involve contacting the flavored fluid or exhaust gas with a membrane or filter, wherein the membrane or filter is configured to retain flavoring or non-flavoring components in the flavored fluid and exhaust gas. The membrane may include polymers such as polyethylene, polypropylene, polyamide, polyimide, cellulose acetate, polysulfone, polydimethylsiloxane, fluoropolymers (e.g., polytetrafluoroethylene (PTFE)), polyvinylidene fluoride (PVDF), ethylene and trichlorofluoroethylene copolymer (ECTFE), perfluorosulfonic acid polymers (e.g., Nafion and Aquivion), nanoporous materials, silica mesoporous materials, zeolites, metal-organic frameworks (MOFs), perovskites, metals, or combinations thereof.
[0133] Flavoring removal units can be inserted before the storage unit or fuel delivery system is inserted into a device such as a fuel cell to consume fuel gases. Alternatively, flavoring removal units can be inserted after the storage unit or the device consuming fuel gases. After removal, the flavoring concentration should be below a critical concentration that negatively impacts fuel cell performance (e.g., below a concentration that reduces efficiency). Other processes that may require the removal of flavorings, embrittlement inhibitors, and / or additives from processed fluids include chemical processes (e.g., hydrogenation and reduction reactions, metal hydride synthesis); petrochemical processes (e.g., hydrocracking, reforming, desulfurization); steel production (e.g., using direct reduced iron (DRI)); glass production; semiconductor and electronics manufacturing processes (including cleaning, annealing, epitaxy, doping, ion implantation, passivation, chemical vapor deposition (CVD), physical vapor deposition (PVD), atomic layer deposition (ALD), plasma etching, atomic layer etching (ALE), diborane and digermanane stabilization, and EUV light generation); cement production or processing; and other emerging technologies. The deodorizer removal should also be sufficient to dilute the treated fluid in ambient air without causing false alarms or warnings of leaks.
[0134] Compounds (or combinations of compounds) in the treated fluid composition, such as terminal alkynes or terminal olefins, can be at least partially consumed by the fuel cell, thereby improving the performance of the fuel cell, increasing the energy produced by the fuel cell, or a combination thereof, relative to a fuel cell operating with a fluid composition that does not contain the compounds or compositions described herein.
[0135] Methods of transporting or storing treated fluids This document also provides methods for transporting or storing materials, such as treated fluid compositions. In some embodiments, the method includes (i) providing any one or more of the treated fluids provided herein, and (ii) placing the treated fluid in a device at least partially formed of metal. The device may be entirely formed of metal. The metal may include any metal or alloy susceptible to hydrogen embrittlement. In some embodiments, the device includes pipes, tanks, storage containers, etc.
[0136] In some embodiments, compounds (or combinations of compounds) such as those provided herein, such as terminal alkynes or terminal olefins, or compositions comprising compounds (or combinations of compounds), can prevent, delay, reduce, or inhibit hydrogen embrittlement of metals. As used herein, the phrase "hydrogen embrittlement" refers to mechanical damage that occurs in a metal due to hydrogen binding to and penetrating into the metal, resulting in a loss of ductility and tensile strength. This loss of ductility and tensile strength subsequently leads to the initiation and propagation of cracks in the metal. Those skilled in the art will recognize that cracks in metals used to store fluids such as hydrogen in storage devices such as pipes or tanks can lead to undesirable leaks and potentially catastrophic failure of the storage device. As used herein, the phrase "prevent, delay, reduce, or inhibit hydrogen embrittlement of metals" indicates that the compound or composition has a positive displacement effect. A positive displacement effect is a quantitative prediction of the compound's ability to prevent hydrogen from binding to a metal or metal surface. In practice, the compound binds to the metal surface, preventing or reducing the ability of hydrogen to bind to the metal surface (i.e., the compound displaces hydrogen). A larger positive displacement efficacy (greater than 0 eV) indicates a higher affinity of the compound for the metal surface and that hydrogen is displaced by the compound. In embodiments, the treated fluid contains a compound having a positive displacement efficacy greater than 0 eV, at least 0.1 eV, at least 0.5 eV, at least 0.75 eV, at least 1 eV, at least 1.5 eV, at least 2 eV, at least 2.5 eV, at least 3 eV, at least 3.5 eV, or at least 4 eV. In a preferred embodiment, the treated fluid contains a compound having a positive displacement efficacy greater than or equal to 0.1 eV.
[0137] Fracture toughness is a measure of the stress required to propagate a pre-existing defect, such as a defect on the surface or in the bulk of a metal or alloy. Defects include, but are not limited to, cracks, voids, metallurgical inclusions, weld defects, design discontinuities, and material bulk defects. Material bulk defects can be transgranular or intergranular, and may or may not be caused by embrittlement. Fracture toughness is expressed by K (stress intensity factor) and J (J integral), and is a measure of a material's ability to resist crack initiation and propagation by testing its fracture toughness. The K value represents the highest stress intensity factor that a material can withstand when crack initiation occurs under a given load or work. The J value represents the work (energy) that a material can withstand per unit fracture surface area at crack initiation. K and J can have various definitions as described in ASTM E1823 and can be measured using different test methods defined in, for example, ASTM E647, ASTM E1820, ASTM E1681, and ASTM E399. Other standard measurement methods for K and J include, but are not limited to, ASTM, ISO, JIS, and CEN. Embodiments of the present invention describe a treated fluid comprising a compound that improves the fracture toughness (measured by K) of a metal or alloy, and the work required to generate a crack in the material when the material is also exposed to hydrogen (H2) (measured by J). Embodiments of the present invention also describe a treated fluid composition comprising one or more compounds and hydrogen, wherein the fracture toughness of the metal or alloy is improved upon contact with this treated fluid composition compared to when the metal or alloy is only in contact with hydrogen (i.e., in the absence of the compound).
[0138] In a preferred embodiment, the treated fluid contains a compound that increases the fracture toughness of the metal or metal alloy by at least 5% compared to the fracture toughness measured when the treated fluid does not contain the compound. Alternatively, the treated fluid contains a compound that increases the fracture toughness of the metal by at least 10%, at least 25%, or at least 50%. In one embodiment, the treated fluid is preferably hydrogen. In one embodiment, the treated fluid contains hydrogen and a compound, wherein the presence of the compound increases the fracture toughness of the metal by at least 5%, at least 10%, at least 25%, or at least 50% compared to a treated fluid containing only hydrogen.
[0139] Example This disclosure is further illustrated by the following embodiments, which should not be construed as limiting the scope of the technology in any way. After reading this description, those skilled in the art will conceive of various other aspects, embodiments, modifications, and equivalents without departing from the spirit of this disclosure or the scope of the appended claims.
[0140] Example 1 Modeling was completed to predict the positive displacement efficacy of various compounds in hydrogen. For simplicity, iron in the Fe(100) surface configuration (defined by the Miller index) was used as a proxy representation of the steel surface for these calculations. The calculations in this embodiment are performed according to the following procedure: (i) obtaining the chemical structure of the compound of interest in SMILES format using a molecular editor (e.g., PerkinElmer's ChemDraw); (ii) importing the molecular structure in SMILES format into VASP (Vienna Ab initio Simulation Software Package) software for calculation using high-performance computing resources; (iii) optimizing the molecular geometry of each compound; (iv) importing the optimized geometry into the Fe(100) laminate model surface; (v) performing ab initio molecular calculations on the optimized conformation (as determined in (iii)) and finding the optimal docking position that minimizes the energy on the Fe(100) laminate surface; (vi) optimizing the geometry of the molecules docked on the Fe(100) laminate surface; (vii) evaluating the final docking conformation (e.g., the feasibility and stability of the optimized compound geometry on the Fe(100) surface); (viii) determining the binding energy (E) of the docked molecules on the Fe(100) laminate surface. b,mol (ix) Calculation of H2 substitution efficiency (E) b,H2 – E b,Mol ).
[0141] Using this method, the dissociative chemisorption (E) of H2 on Fe(100) can be predicted. b,H2 The binding energy is -1.7 eV. Compounds with binding energies lower than the chemisorption binding energy of H2 tend to bind to the Fe(100) surface, and consequently to the steel surface. Compared to hydrogen, compounds with lower binding energies interact more readily with the Fe(100) surface, thereby reducing the hydrogen concentration on the surface. In a sense, this reduces the likelihood of hydrogen entering the metal bulk and causing embrittlement of the metal or alloy (e.g., steel).
[0142] The H2 replacement efficiency of 0 eV is equal to that of hydrogen dissociation chemisorption (e.g., E). b,H2 – E b,MolThe displacement effect is -1.7 eV – (-1.7 eV) = 0 eV. For all other compounds, a positive displacement effect indicates that the compound displaces hydrogen on the Fe(100) surface, which means there is a positive Gibbs free energy (ΔG), favoring the chemisorption reaction on the surface. This indicates that the diffusion of hydrogen into the bulk material (metal) is reduced, thus also reducing (or inhibiting) embrittlement. A negative displacement effect indicates that hydrogen is more favored on the Fe(100) surface than the compound, which means there is a negative Gibbs free energy (ΔG), favoring the chemisorption of hydrogen. A negative displacement effect indicates that the presence of the compound does not reduce the diffusion of hydrogen into the bulk material, thus leading to embrittlement.
[0143] Calculations were performed to compare the H2 substitution efficacy of known hydrogen embrittlement inhibitors with other compounds, including those used in this invention disclosed herein. The results of these calculations are shown in the table below.
[0144] The results of Example 1 demonstrate that the terminal alkyne compounds disclosed herein (Examples 1.1-1.6) unexpectedly exhibit similar or better hydrogen replacement efficacy compared to known hydrogen embrittlement inhibitors (Comparative Examples 1.7-1.9). This indicates that these compounds effectively inhibit or prevent hydrogen embrittlement by limiting hydrogen binding to the material surface. These compounds have a high affinity for chemisorption on metal surfaces compared to hydrogen, thereby preventing hydrogen interaction with the surface and reducing the likelihood of embrittlement caused by hydrogen absorption and migration to the metal bulk. In contrast, non-terminal alkenes and alkynes (Comparative Examples 1.10-1.14 and Example 1.15) show a significantly lower tendency to replace hydrogen on surfaces. These compounds have a lower chemisorption affinity on metal surfaces compared to hydrogen, which favors hydrogen interaction with the surface and increases the probability of embrittlement caused by hydrogen absorption and migration to the metal bulk. Surprisingly, diynes (e.g., 1,5-hexamethylenediyne) are more effective at displacing hydrogen than other compounds used as embrittlement inhibitors, suggesting that these compounds bind more readily to metal surfaces, thereby inhibiting or preventing hydrogen embrittlement by limiting hydrogen uptake into the metal. Without being bound by theory, this result may at least be attributed in part to the chelating effect of the interaction between the two terminal alkyne bonds and a metal center.
[0145] Example 2 Stability testing was conducted at 90°C using a 6-meter-long seamless stainless steel (Alloy 316) tube with a diameter of ¼ inch and a wall thickness of 0.035 inches. A heated water bath was used to control the temperature. Treated (e.g., flavored) hydrogen gas was passed through the tube at a flow rate of 0.8 mL / min, resulting in a residence time of approximately 2 hours. The gas flow rate was analyzed using a VARIAN™ CP-4900 Pro miniature gas chromatograph (Varian, Inc., USA), with samples taken every 3 minutes.
[0146] By administering 50-100 mg / m³ in a gas cylinder at a pressure of approximately 100 bar 3 Organic compounds of n are mixed with hydrogen gas to prepare diluents for various flavoring agents. Hydrogen cylinders are prepared using the gravimetric method as defined in ISO 6142.
[0147] The results of these tests are as follows Figure 1 , Figure 2 and Figure 3 As shown. Figure 1 The graph shows the relationship between the concentration of 1,6-heptaacetylene in hydrogen (in ppm (mol)) and time during a stability test conducted at 90 °C. Figure 2 The relationship between the concentration of cis-2-pentene in hydrogen (in ppm (mol)) and time was plotted during a stability test conducted at 90 °C. Figure 3 A graph depicting the concentration of 2-pentyne in hydrogen (in ppm (mol)) versus time during stability tests conducted at 90 °C is presented. Data from Example 2 confirm the results of the computational model used in Example 1. Embodiments with terminal unsaturated bonds (e.g., alkynes and alkenes), such as 1,6-heptadiyne, unexpectedly exhibit good chemisorption properties on steel surfaces, while non-terminal alkenes (e.g., cis-2-pentene) and non-terminal alkynes (e.g., 2-pentyne) do not interact with the steel surface. Figure 1 As shown, when the steel pipe is heated to 90°C, the concentration of 1,6-heptadiyne in hydrogen gas increases rapidly, confirming the desorption of the compound from the steel surface. Upon cooling, the concentration of 1,6-heptadiyne decreases slowly, confirming the chemisorption of the compound on the steel surface. The chemisorption characteristics (concentration increasing and decreasing with temperature) are further confirmed by the absence of degradation products, indicating that the concentration change is due to chemisorption. For cis-2-pentene ( Figure 2 ) and 2-pentyne ( Figure 3No such behavior was observed. Data suggest that compounds with terminal unsaturated bonds (such as alkynes and alkenes) described herein may be suitable inhibitors of hydrogen embrittlement due to their strong chemisorption onto steel. Without being bound by theory, it appears that terminal alkynes form a layer on the metal surface, which reduces hydrogen binding on the metal surface and hydrogen absorption and migration into the bulk metal, thereby preventing or reducing embrittlement.
[0148] Example 3 Diluted solutions of various flavoring agents are prepared by mixing organic compounds in pure hydrogen gas (grade 5.0) in a 1500 psi cylinder. The hydrogen cylinder is prepared by gravimetric method as defined in ISO 6142.
[0149] The embrittlement of the steel was evaluated under ASTM E1820 test conditions. The autoclave chamber was filled with 1500 psi of hydrogen or flavored hydrogen. The embrittlement properties of the steel were measured using specimens made of AISI 4617 carbon steel with the following dimensions:
[0150] The fracture toughness test results, expressed in terms of J (J integral) and K (stress intensity factor), were determined under the following test conditions: elastic modulus (Young's modulus) = 29000 KSI; Poisson's ratio = 0.32; and dK / dt = 0.005 N / mm². 3 / 2 s.
[0151] For the purposes of this invention, K and J are determined by the JR curves measured according to the ASTM E1820 guideline and measured at different crack propagation locations: 0 mm crack propagation (representing the toughness at the start of crack propagation / crack initiation (K0 and J0)), 0.2 mm crack propagation (K0 and J0)). J0.2mm and J 0.2mm ), 1.0 mm crack propagation (indicating the slope of the JR curve (K) J1mm and J 1mm )) and P as defined in ASTM E1820 max Maximum load under the condition (K) MAXLOAD and J MAXLOAD The table below shows the effects of various embrittlement inhibitors on J and K under different crack propagation and maximum load conditions. J The impact of the value.
[0152] The data shown in Example 3 demonstrate that terminal alkynes and olefin compounds act as embrittlement inhibitors when added to hydrogen. Hexyl-1-yne, hexyl-1,5-diene, and 1,7-octadiene exhibit higher J and K values compared to pure hydrogen, indicating a reduction in the susceptibility of steel to hydrogen embrittlement when these compounds are used as inhibitors. Hexyl-1-yne also provides similar embrittlement protection against crack initiation (K0, J0) compared to known embrittlement inhibitors (i.e., ethanethiol and oxygen), further demonstrating the compound's suitability for this purpose. Under crack propagation greater than 0 mm and maximum load, hexyl-1,5-diene significantly outperforms ethanethiol as a hydrogen embrittlement inhibitor, showing a surprisingly improved effectiveness. Unexpectedly, under crack propagation greater than 0 mm and maximum load, the performance of hexyl-1,5-diene is also similar to that of oxygen, which is considered one of the best hydrogen embrittlement inhibitors. Its performance is also unexpectedly much better than that of 1,7-octadiene. The fracture toughness values of non-terminal alkynes (e.g., hex-2-yne) are similar to those of pure hydrogen, indicating that these compounds do not inhibit embrittlement, as shown by the results of Examples 1 and 2. Surprisingly and unexpectedly, among the compounds tested, only terminal alkynes and alkenes are suitable inhibitors of hydrogen embrittlement.
[0153] Comparative Example 3.10 used 40 ppm of oxygen and was used to compare data at all 40 ppm levels. Surprisingly, 1-hexene was less efficient than 1-hexyne and 1,5-hexadiene, and unexpectedly, 3,3-dimethyl-1-butyne, as one of the best hydrogen embrittlement inhibitors, performed similarly to 1,5-hexadiene. Advantageously, 3,3-dimethyl-1-butyne also has almost no odor, which is an advantage at high concentrations (no odor masking) when mixed with flavoring compounds. THF and propanol are examples of other poorly performing, ineffective inhibitors, similar to ethanethiol and pure hydrogen (no effect).
[0154] Example 4 Diluted solutions of various flavoring agents are prepared by mixing organic compounds in water to create concentrated solutions based on the water solubility of the organic compounds. The concentrated solutions are then dissolved in water to achieve the desired concentration. The actual concentration in the top space of the vial and the concentration exposed to the group members vary depending on the vapor pressure of the compound being tested and its diffusion in the air.
[0155] Using a method similar to that disclosed in the literature (Journal of Applied Toxicology, 3, 272-289, 1983; Perception & Psychophysics, 39, 281-286, 1986) and an olfactory panel of at least 8 members, flavoring solutions of different concentrations were evaluated by olfactory testing.
[0156] In this embodiment, the odor characteristics of each flavoring agent were ranked from 1 (extremely unpleasant) to 10 (extremely pleasant). Each participant also described the flavoring agent. Participants were exposed to concentration variations of 10-fold to determine odor detection thresholds from 0.001 mg / L to 10 mg / L. The odor detection threshold represents the lowest concentration of flavoring agent that a panel member could detect. The odor characteristic score for each compound was calculated by averaging the scores (1-10) reported by each panel member for each dilution, and the lowest score for each compound (independent of dilution) is reported in the table below.
[0157] *Decided by group members **1 (extremely unpleasant) and 10 (extremely pleasant)** Data shows that when used as flavoring agents, some compounds exhibit performance similar to THT (e.g., similar odor detection thresholds and / or odor characterization scores). In the cases of hex-1-en-5-yne (Example 4.5), hepta-1-en-6-yne (Example 4.6), penta-1-yne (Example 4.7), hex-1-yne (Example 4.8), hepta-1,6-diyne (Example 4.15), oct-1,7-diyne (Example 4.16), methylpropynyl ether (Example 4.17), 3-ethoxyprop-1-yne (Example 4.18), 3-(prop-2-oxy)-prop-1-yne (Example 4.19), and hex-2-yne (Example 4.25), these compounds provide an odor comparable to or stronger than THT at similar concentrations.
[0158] Example 5 By mixing 50-100 mg / m³ of pure hydrogen (grade 5.0) in a 100 bar cylinder. 3 Each compound of n is used to prepare diluents for various flavorings. Hydrogen cylinders are prepared using the gravimetric method as defined in ISO 6142.
[0159] The flavored hydrogen sample was mixed with air at ratios ranging from approximately 50:1 to 2000:1. Members of the olfactory panel were asked to provide their impressions of the odor characteristics and indicate whether they found the flavoring unpleasant (e.g., whether the odor would cause serious concern if smelled in a real-world application). The odor threshold was determined by progressively increasing the concentration. Starting with a dilution of 1:2000, the concentration was doubled at each step. In some cases, the flavoring was still detectable even at the highest dilution (the lowest concentration tested). In other cases, the flavoring was not detectable even at the highest concentration tested. For flavorings where this occurred, the odor detection threshold and nominal odor concentration were reported as less than (<) or greater than (>) the known concentration.
[0160] The nominal concentration of odor intensity was determined by comparing the odor intensity of each compound to a set concentration of the flavoring agent tetrahydrothiophene (THT). This allows for the quantification of the concentration of test compounds that match the odor intensity of THT. The THT concentration was set to approximately 1% v / v of the nominal concentration, thus using a typical gaseous flavoring concentration of THT (18 mg / m³). 3 n; 5.0 ppmmol) simulates the typical detection concentration of 20% of the lower explosive limit of hydrogen (LEL = 4% v / v in air, approximately 0.8% v / v in air) and natural gas (LEL = 5% v / v in air; approximately 1% v / v) in air.
[0161] Preferably, a lower concentration of the flavoring agent is used to achieve the same odor intensity as THT, which indicates that the odor intensity curve defined in ISO / DTS 18222 has a steeper slope and that the compound has a lower odor detection threshold compared to THT. Preferably, the lower concentration is sufficient to achieve a warning odor level, but the concentration of the flavoring agent should at least produce an odor similar to THT.
[0162] The results of Example 5 are provided in the table below. The data show that some compounds, when used as flavoring agents, exhibit properties similar to THT. In the cases of hepta-2-yne (Example 5.1), hex-1-yne (Example 5.6), hex-1-en-5-yne (Example 5.9), hepta-1,6-diyne (Example 5.11), and hex-2-yne (Example 5.16), the compounds provided an odor comparable to or stronger than THT at similar concentrations. In other examples, including Example 5.1 (hepta-2-yne) and Example 5.6 (hex-1-yne), these compounds provided an odor comparable to or stronger than THT at lower concentrations. Both are desirable properties for selecting a suitable flavoring agent.
[0163] *Decided by the group members.
[0164] **The required concentration to match the odor intensity of 1% v / v THT ^Dilution equipment reaches operating limit The data shown in Examples 1 through 5 demonstrate that terminal alkyne compounds can be dual-purpose compounds, acting as both flavoring agents and embrittlement inhibitors. Odor properties, including a warning odor at relatively low concentrations, are comparable to or better than other typical commercial natural gas flavorings such as THT. This is particularly true for short-terminal alkynes (such as pentylo-1-yne and hexylo-1-yne), enynes (such as hexylo-1-en-5-yne), and diynes (such as hept-1,6-diyne). Surprisingly, in addition to acting as flavoring agents, these compounds can also form a layer on steel surfaces that prevents hydrogen embrittlement, likely due to chemisorption of the compounds on the steel.
[0165] Surprisingly and unexpectedly, the data shown in Examples 1 through 5 indicate that some terminal alkyne compounds can inhibit embrittlement without interacting with the warning odor of another compound acting as a flavoring agent (e.g., masking the odor of the flavoring agent). This is particularly true for bulky terminal alkynes such as 3,3-dimethylbut-1-yne, 4-methylpent-1-yne, and 5-methylhex-1-yne, ultra-long alkynes such as oct-1-yne and hept-1-yne, and cyclic terminal alkynes such as ethynylcyclopropane. Bulky terminal alkynes require significantly higher concentrations to detect their odor and provide odor intensity comparable to THT. It is expected that the odor characterization of the fluid will be primarily determined by another compound acting as a flavoring agent, rather than primarily by bulky terminal alkynes acting as embrittlement inhibitors. Alternatively, the concentration of bulky terminal alkynes in the fluid could be increased to match odor intensity comparable to THT, thus allowing the terminal alkynes to function as both effective embrittlement inhibitors and flavoring agents.
[0166] Surprisingly and unexpectedly, the data shown in Examples 1 through 5 indicate that terminal olefin compounds can inhibit embrittlement without interacting with the warning odor of another compound acting as a flavoring agent (e.g., masking the odor of the flavoring agent). This is true, for example, for terminal olefins (such as 1-hexene and 1-octene) and terminal dienes (such as 1,5-hexadiene and 1,7-octadiene). Terminal olefins may require significantly higher concentrations to be detected and provide odor intensity comparable to THT. It is anticipated that the odor characterization of the fluid will likely be determined primarily by another compound acting as a flavoring agent, rather than primarily by the terminal olefin acting as an embrittlement inhibitor. Alternatively, the concentration of terminal olefins in the fluid could be increased to match the odor intensity comparable to THT, thus enabling the terminal olefins to function as both an effective embrittlement inhibitor and a flavoring agent.
[0167] The data shown in Examples 4 and 5 demonstrate that enyne compounds are suitable flavorings for fluids, particularly gases. The odor characteristics and warning odor features of the enyne compounds are comparable to typical commercial natural gas flavorings (THTs) and other alkynes considered gaseous flavorings (e.g., pentylene). Surprisingly, the embodiments of the enyne compounds exhibit odor detection levels equal to or better than some alkynes (e.g., pentylene); odor intensity equal to or better than some alkynes and typical commercial natural gas flavorings (THTs); significantly lower odor detection thresholds compared to similar dienes and alkynes (e.g., 1-heptyne, 1-octyne, and 1,5-hexadiene); and significantly worse odor characteristics compared to similar alkenes, dienes, and alkynes (e.g., 1-hexene, 1-heptyne, and 1,5-hexadiene). These are desirable properties when selecting flavoring compounds.
[0168] Example 6 By mixing organic compounds in hydrogen (grade 5.0 hydrogen), approximately 120 mg / m³ was achieved in a 100 bar cylinder. 3 Various flavoring agent diluents were prepared using a concentration of n. The hydrogen cylinder was prepared using the gravimetric method as defined in ISO 6142. The proton exchange membrane fuel cell (PEMFC) system was manufactured by Proton Technologies in the Netherlands. It utilizes Proton Technologies' 8 cm... 2 The battery was tested. The membrane electrode assembly (MEA) was a Proton Technologies Ames MEA, with the anode made of 0.075 mg Pt / cm³. 2 (HyPer Pt / C 40%wt) is used, and the cathode is composed of 0.3 mg Pt / cm. 2 Composed of (HyPer Pt / C 40%wt), located on Nafion 211 support.
[0169] The following parameters are used for PEMFC testing:
[0170] Before testing the flavoring agent, the PEMFC battery was purged with pure hydrogen. T=0 was defined as the time required to inject flavored hydrogen into the PEMFC and bring it into operation. At a constant 1 A / cm² temperature... 2 At current output, changes in potential (e.g., voltage) are correlated with the effect of flavorings on fuel cell performance during exposure to flavorings. For each MEA batch, a reference load was measured using pure hydrogen (grade 5.0) without flavorings to determine the baseline performance of the MEA batch and to allow comparison of the degradation effects of each flavoring. The results are shown in the table below.
[0171] Figure 4 , Figure 5 , Figure 6 , Figure 7 , Figure 8 , Figure 9 , Figure 10 , Figure 11 , Figure 12 and Figure 13 It shows 1 A / cm 2 The evolution of potential (V) during durability testing in a PEMFC under current load. As shown in the figure, hexyl-1-yne (Example 6.4) Figure 7 ), hex-1-en-5-yne (Example 6.5) Figure 8 ), hepta-1-en-6-yne (Example 6.6) Figure 9 ), 3,3-dimethyl-but-1-yne (Example 6.7) Figure 10 ), hex-1,5-diene (Example 6.8) Figure 11 ), hex-1-ene (Example 6.9) Figure 12 ) and hexyl-2-yne (Example 6.10) Figure 13 The performance of the PEMFCs showed similar trends to the reference. The absolute difference in performance between the reference and hydrogen flavored with these compounds may be attributed to the variability in MEA manufacturing.
[0172] like Figure 14 As shown, compared with the reference test using pure hydrogen, the performance of PEMFC using butyraldehyde (Comparative Example 6.11) exhibited a rapid decline in performance within the first 15-30 minutes (as shown by a potential drop of 120 mV), followed by a slower performance loss for the remainder of the test period (a potential drop of 100 mV).
[0173] like Figure 15 As shown, the performance of PEMFC using THT (Comparative Example 6.12) drops rapidly after 5 minutes of operation.
[0174] The durability tests conducted at high flavoring concentrations in Example 6 demonstrate that the olefins and alkynes according to the invention are suitable for stable PEMFC operation. Surprisingly and unexpectedly, despite strong interactions with metals and alloys such as iron and steel, the terminal olefins and alkynes according to the invention do not exhibit negative interactions with the metal used as a catalyst in the PEMFC (the platinum catalyst used in Example 6). Even at very high concentrations (approximately 10 times higher than normal gas flavoring levels), at a constant 1 A / cm²... 2Under battery current, the potential (voltage) remains or increases over approximately 20-24 hours. Furthermore, compared to known hydrogen flavoring agents based on alkyne moieties (e.g., pentyne), the alkynes according to the invention exhibit a similar effect on the performance of PEMFCs over time; in Examples 1-3, the alkyne moieties have been shown to have no or very weak interaction with metal surfaces. Moreover, the olefins and alkynes according to the invention exhibit significantly better performance compared to known toxic substances used in PEMFCs such as aldehydes (e.g., butyraldehyde, Comparative Example 6.11) and sulfur-containing compounds (e.g., THT, Comparative Example 6.12), which are known to interact with metal surfaces through sulfur-metal or oxygen-metal coordination or van der Waals chemical interactions, thereby producing toxic effects. This data demonstrates the feasibility of using the olefins and alkynes according to the invention as hydrogen flavoring agents in fuel cell operation.
[0175] Example 7 The performance of various antioxidants was tested in a 100 mL 316L stainless steel autoclave equipped with a single-bottom impeller and mixed at 500 rpm. 20 g of 2-hexyne or 1-hexyne was added to the autoclave, followed by the appropriate amount of the antioxidant to be tested (ppm by weight). The mixture was then incubated at 50°C in air at 500 psig for 24 hours. The purity of the product was determined by gas chromatography before and after air exposure. Analysis was performed using an Agilent 8890 system equipped with a J&WHP-5 column.
[0176] In a 250 mL Erlenmeyer flask, add 50 mL of 2-propanol (CAS #67-63-0, 99.999% purity), 1 mL of 16.67 wt% potassium iodide aqueous solution (CAS #7681-11-0, 99% purity), and 1 mL of glacial acetic acid (CAS #64-19-7, >99% purity). The Erlenmeyer flask is equipped with a magnetic stir bar and stirred at 200 rpm. Add the analyte alkyne in quantities ranging from 0.05 to 1 gram, depending on the peroxide concentration. Boil the reaction mixture and maintain the boiling temperature for one minute until it turns yellow. If the reaction mixture remains colorless, use a larger amount of the analyte alkyne. If the reaction mixture turns orange, use a smaller amount of the analyte alkyne. After cooling the reaction mixture to room temperature, titrate the solution with a 0.01N sodium thiosulfate aqueous solution (CAS #7772-98-7, 99% purity) until the color completely disappears. The amount of sodium thiosulfate aqueous solution used is recorded as a "volume equivalent". The amount of peroxide in alkynes is calculated using the following equation: Peroxide concentration (ppmw) = 8000 * ((volume equivalent * 0.01) / sample mass).
[0177] The antioxidant properties of the following compounds were tested.
[0178] These compounds possess the following physicochemical properties.
[0179] nd = No data found The table below lists the olfactory properties of these compounds from different literature sources.
[0180] nd = No data found The table below shows the GC purity before and after exposure to oxygen and the peroxide levels after aging, determined by titration of alkyne samples containing or without the compounds listed in the table using the procedure described above. The difference between the initial and final GC purity may reflect the efficiency and ability of the compounds to inhibit oxidation and degradation. Alkynes tested without antioxidants (Comparative Examples 7.1-4) showed significant degradation during testing, as evidenced by lower purity and increased peroxide content after aging. Similarly, the commonly used gas flavoring agent THT (Comparative Example 7.5) also showed a loss of purity during testing. This loss indicates that the purity loss of alkynes is acceptable if used as a gas flavoring agent. For the purposes of this test, any added compound that resulted in a purity reduction of less than 1% and / or a peroxide level of less than 400 ppmw after aging was considered effective.
[0181] *At the end of the experiment, the compound appeared not to have completely dissolved.
[0182] Based on the above data, acetic acid (Examples 7.16-7.17), diisopropylmethanol (Examples 7.26-7.29), diisopropyl ketone (Examples 7.30-7.32), DMSO (Example 7.38), amyl acetate (Example 7.40), methyl sorbate (Example 7.44), carbazide (Example 7.45), methyl salicylate (Example 7.52), and benzyl alcohol (Example 7.53) are not considered effective stabilizers for protecting alkynes from re-oxidation. The results obtained with carbazide (Example 7.45) highlight the crucial importance of antioxidant solubility in alkynes for preventing oxidative degradation.
[0183] Surprisingly, amine-based compounds such as DABCO (Example 7.34), triethylamine (Example 7.35), and DEHA (Example 7.39) exhibit antioxidant properties similar to or better than those of the well-known antioxidant diphenylamine (Examples 7.22-7.25). Considering their respective physicochemical properties and reported toxicity, DEHA and triethylamine are preferred over diphenylamine. Nevertheless, according to ISO 14687:2019, the concentration of amine antioxidants in the hydrogen phase should be limited to a maximum of approximately 0.05 ppm (molecular weight) to avoid performance problems during fuel cell operation; this specification limits the concentration of ammonia (NH3) to 0.1 ppm (molecular weight). Assuming an alkyne concentration of 5 ppm (molecular weight) as a flavoring agent, the alkyne flavoring composition may contain up to approximately 1000 ppmw of amine-based antioxidant.
[0184] Surprisingly, despite reports that amyl acetate (Example 7.40) and methyl salicylate (Example 7.52) are additives in acrylate-based gaseous flavoring formulations (WO2006067111A1 and WO2006067115A1), they are not effective as stabilizers or antioxidants for alkynes. Similarly, although equivalents of sodium, calcium, and potassium sorbate, as well as sorbic acid, are used as food preservatives, methyl sorbate (Example 7.44) is not an effective stabilizer or antioxidant for alkynes. The same conclusion applies to benzyl alcohol (Example 7.53). It is a known antioxidant used in food and cosmetic applications, but not an effective stabilizer or antioxidant for alkynes. These results highlight the need for careful selection of antioxidant compounds, and that the effectiveness of previously reported stabilizers and antioxidants for alkynes remains unclear.
[0185] Surprisingly, not all phenolic derivatives performed in the same way. Compared to all other phenolic derivatives, TBHQ (Example 7.36) and methyl salicylate (Example 7.52) showed poorer oxidant protection, considering the reduced purity and / or peroxide concentration. These results again highlight the need for careful selection of antioxidant compounds, and that the effectiveness of previously reported stabilizers and antioxidants on alkynes remains unclear.
[0186] Surprisingly, isopropanol (Examples 7.10-7.15 and 7.42-7.43) and acetone (Examples 7.17-7.22) were as effective as well-known antioxidants such as BHT and BHA, especially at concentrations above 10,000 ppmw. These results were even more surprising compared to those of diisopropylmethanol (Examples 7.26-7.29) and diisopropyl ketone (Examples 7.30-7.32), which have similar chemical structures but are less effective antioxidants.
[0187] Based on these results, triethylamine, DEHA, cresol, ethylphenol, 2-methoxy-4-methylphenol, and 2-methoxyphenol are ideal candidates, considering their physicochemical properties such as low melting and / or boiling points and reasonable vapor pressures. Among the tested antioxidants, triethylamine, DEHA, 2-ethylphenol, 3-ethylphenol, 2-methoxy-4-methylphenol, and 2-methoxyphenol are preferred, taking into account their toxicity and olfactory properties.
[0188] For compounds with high melting points (greater than 50°C) and boiling points (greater than 200°C), BHA is superior to BHT, TBHQ, resorcinol, diphenylamine, and DABCO, based on the absence of color formation after oxidant testing, low peroxide content, low byproduct formation, low toxicity, and expected better compatibility with fuel cells due to the absence of nitrogen atoms. For compounds with high melting points (greater than 50°C) and boiling points (greater than 200°C), the maximum concentration in the flavoring formulation should not exceed 1000 ppmw, preferably equal to or less than 200 ppmw, to comply with the technical guidelines defined in ISO 13734:2013, which requires that the mass fraction of flavoring residue after evaporation be less than 0.2 wt%. Above 1000 ppmw, flavoring compositions containing antioxidant compounds may not completely vaporize during gas flavoring, leading to precipitation, deposition on pipe walls, and / or blockage of the flavoring injection system.
[0189] Example 8 A gaseous mixture of 1-hexyne and various antioxidants was prepared in multiple steps. First, the mass equivalent to 1000 ± 150 ppmw of antioxidant was added to pure 1-hexyne to form solution A and allow it to dissolve completely. Second, 1 μL of the 1-hexyne and antioxidant solution A was injected into a 5 dm³ container using a liquid syringe. 3 Pure hydrogen (grade 5.0) was placed in a Tedlar® gas bag to form gas mixture B. Then, 0.4 dm³ was injected again using a gas injector. 3 Gas mixture B is injected into a container with a capacity of 4.6 dm³ 3 In a second Tedlar® gas bag filled with pure hydrogen (grade 5.0), gas mixture C was formed. Analysis of mixture C by gas chromatography confirmed that the concentration of 1-hexyne was approximately 10 mg / Nm³. 3 Because the concentration of antioxidants in gas mixture C is very low, it is impossible to accurately quantify the antioxidant concentration by gas chromatography. For these tests, the antioxidant concentration in gas mixture C should be considered as an equivalent weight ratio to its original concentration in solution A, corresponding to 0.0100 + / - 0.0015 mg / Nm³. 3 .
[0190] An olfactory team of five members was used to determine the effect of antioxidants on the olfactory properties of 1-hexyne. Team members were exposed through two separate olfactory ports to a reference gas mixture made from pure 1-hexyne and a test gas mixture, the test gas mixture including a specific antioxidant and 1-hexyne mixture not disclosed to the team members. During the testing, team members could move back and forth between the two ports to determine whether the sample containing the antioxidant had different olfactory properties compared to the pure 1-hexyne reference. The pure 1-hexyne reference gas mixture consisted of 10 mg / Nm³ of hydrogen. 3 It consists of a 1-hexyne gas mixture, diluted with clean air to approximately 1% v / v of the nominal concentration, or 0.1 mg / Nm³. 3 The 1-hexyne concentration was determined to simulate a typical detection concentration of 20% of the lower explosive limit (LEL) for hydrogen (LEL = 4% v / v in air; approximately 0.8% v / v in air) and natural gas (LEL = 5% v / v in air; approximately 1% v / v in air). Test gas mixtures were prepared by adjusting the dilution factor of each gas mixture C to achieve a concentration of 0.1 mg / m³ in the gas phase, based on the nominal 1-hexyne concentration determined by gas chromatography. 3 The same final concentration of 1-hexyne and approximately 0.0001 mg / Nm 3 Antioxidant concentration.
[0191] Each member of the olfactory panel was asked to provide their impressions of the odor characteristics and intensity of the test gas mixture, including an undisclosed antioxidant, compared to a pure 1-hexyne reference. Panel members were asked to indicate whether they found the test gas sample unpleasant (e.g., whether the odor would cause serious concern if smelled in a real-world application), and whether the odor characteristics and intensity were comparable to the pure 1-hexyne reference. If panel members concluded that the odor characteristics and intensity of the test gas sample were comparable to the pure 1-hexyne reference, then the odor characteristics of the 1-hexyne and antioxidant gas mixture C were considered comparable to pure 1-hexyne. If panel members concluded that the test gas sample had a different odor characteristic (an odor different from the pure 1-hexyne reference sample), then the odor characteristics of the 1-hexyne and antioxidant gas mixture C were considered different from pure 1-hexene. If panel members concluded that the test gas sample had a different odor intensity (higher or lower odor intensity), then the antioxidant was considered to have a synergistic effect (higher odor intensity) or an antagonistic effect (lower odor intensity, odor masking) compared to pure 1-hexyne.
[0192] The results are presented in the table below. In this table, A, B, C, D, and E represent the feedback from the five panel members. The data show that some antioxidants affect the odor characteristics of 1-hexyne. In the cases of Example 8.1 (3-ethylphenol), Example 8.2 (p-cresol), Example 8.4 (2-ethylphenol), and Example 8.5 (DEHA), some panel members observed different olfactory characteristics. For the other examples, the olfactory characteristics of the mixture of 1-hexyne and antioxidant, as well as pure 1-hexyne, were the same.
[0193] Surprisingly, in all embodiments, the presence of antioxidants in 1-hexyne did not affect the warning properties of 1-hexyne compared to pure reference 1-hexyne, although some panel members observed olfactory differences. Some panel members found differences in the odor characteristics of Example 8.1 (3-ethylphenol) and Example 8.4 (2-ethylphenol). This was considering the antioxidant concentration (approximately 0.0001 mg / m³). 3 The odor detection thresholds were significantly lower than those reported in the literature, which was quite surprising for Example 8.4 (2-ethylphenol). For both compounds, the unpleasant odor was retained; therefore, it can be concluded that the presence of 2-ethylphenol or 3-ethylphenol does not adversely affect the performance of 1-hexyne as a flavoring agent. According to feedback from some panel members, their presence actually exacerbated the warning and unpleasant olfactory characteristics. Some panel members also found differences in odor intensity for Example 8.1 (3-ethylphenol), Example 8.2 (p-cresol), and Example 8.5 (DEHA). Since an equal number of panel members reported lower or higher odor intensities for Example 8.1 (3-ethylphenol) and Example 8.5 (DEHA), it can be assumed that these two antioxidants have no effect on the olfactory properties of 1-hexyne. Surprisingly, the data collected for Example 8.2 (p-cresol) indicated that p-cresol enhanced the odor intensity of 1-hexyne even when panel members did not find differences in odor characteristics.
[0194] For some applications, it is beneficial that the effective concentration of antioxidants in the flavoring agent results in an effective concentration in the air below the odor detection threshold, thus avoiding odor masking or fading. For example, a 10 mg / Nm3 flavoring agent containing 1000 ppmw of antioxidants. 3 When the concentration of alkyne in air is 20% of the hydrogen LEL (i.e., 1% of the air), the concentration of antioxidant in the air during the leak is 0.0001 mg / Nm³. 3To avoid odor masking or fading, the odor detection threshold of antioxidants should be significantly higher than this value to prevent their detection and impact on the odor characteristics of the flavoring agent. Data from Examples 5.3 and 5.5 to 5.8 clearly highlight this behavior. In this regard, compounds such as 3-ethylphenol (Example 5.1) are not ideal antioxidant candidates due to their very low odor detection thresholds. Odor detection thresholds reported in the literature are below 0.0001 mg / Nm³. 3 It is reasonable to expect that the olfactory properties of the flavoring agent will be affected by such compounds, as illustrated in Example 5.1. Given the odor detection thresholds reported in the literature, phenolic compounds such as BHT, BHA, 2-ethylphenol, 4-ethylphenol, m-cresol, 2-methoxy-4-methylphenol, methyl salicylate, and 2-methoxyphenol are preferred. Similarly, given the very high odor detection thresholds reported in the literature, amine-based compounds such as DEHA and diphenylamine are ideal candidates to ensure that the olfactory properties of the flavoring agent are not affected by the presence of the antioxidant at effective antioxidant concentrations. In contrast, significantly higher concentrations of acetone and IPA can be used as antioxidants due to their much stronger odor detection capabilities. Those skilled in the art will expect that even when using IPA or acetone at concentrations up to 50,000 ppmw as antioxidants, the olfactory properties of the flavoring agent will not be affected.
[0195] For some applications, antioxidants can enhance the warning odor of flavorings. This is especially true if the antioxidant has an unpleasant odor, as it can have a synergistic effect with the flavoring. In this regard, 3-ethylphenol (Example 5.1), p-cresol (Example 5.2), and 2-ethylphenol (Example 5.4) are ideal antioxidant candidates because they have very low odor detection thresholds and very unpleasant odor profiles, which positively impact the performance of flavorings. Similarly, despite having high odor detection thresholds, antioxidants such as DEHA, DABCO, triethylamine, 2-methoxyphenol, and 4-ethylphenol enhance the warning characteristics of flavorings due to their highly unpleasant odor profiles.
[0196] Constructive Example 9 Based on the experimental data shown in Examples 7 and 8, the compounds listed in the table below are antioxidants suitable for protecting alkynes from oxidation when used as gas flavoring agents. These compounds possess the following properties:
[0197] aspect The following is a list of non-limiting aspects of this disclosure: Aspect 1. A compound, for example, as a hydrogen embrittlement inhibitor and / or a fluid (e.g., gas) flavoring agent, said compound comprising, being primarily composed of, or consisting of terminal alkynes and / or terminal olefins, wherein, as used herein, the phrases “terminal alkyne” and “terminal olefin” include their substituted and / or heteroatom-containing derivatives.
[0198] Aspect 2. The compound as described in aspect 1, wherein the compound is non-toxic (e.g., non-toxic to humans and / or other animals).
[0199] Aspect 3. The compound as described in aspect 1, wherein the compound has a detectable odor below a toxicity level (e.g., for humans and / or other animals).
[0200] Aspect 4. The compound as described in Aspect 1, wherein the compound is environmentally friendly, for example, it does not cause health, toxicity or ecological problems to humans or other animals.
[0201] Aspect 5. The compound of any one of the preceding aspects, wherein the compound is harmless to the environment as a combustion product when burned, for example, it does not cause health, toxicity or ecological harm to humans or other animals.
[0202] Aspect 6. The compound as described in any of the preceding aspects, wherein the compound does not have an undesirable effect on components of the device system, such as a combustion system, fuel cell, or any other appliance (e.g., the compound does not affect the performance of the device (e.g., energy output), or the effect is less than 1% or less than 0.1%).
[0203] Aspect 7. The compound of any one of the preceding aspects, wherein the positive substitution effect of said compound on hydrogen is greater than 0 eV, at least 0.1 eV, at least 0.2 eV, at least 0.3 eV, at least 0.4 eV or at least 0.5 eV.
[0204] Aspect 8. The compound as described in any of the preceding aspects, wherein the compound acts as an embrittlement inhibitor in any method, composition and / or system reagent kit.
[0205] Aspect 9. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of, or is composed of: a terminal C3-C 20 Alkynes, terminal C3-C 19 Alkynes, terminal C3-C 18 Alkynes, terminal C3-C 17 Alkynes, terminal C3-C 16 Alkynes, terminal C3-C15 Alkynes, terminal C3-C 14 Alkynes, terminal C3-C 13 Alkynes, terminal C3-C 12 Alkynes, terminal C3-C 11 Alkynes, terminal C3-C 10 Alkynes, terminal C3-C9 alkynes, terminal C3-C8 alkynes, or terminal C3-C7 alkynes.
[0206] Aspect 10. The compound of any one of the preceding aspects, wherein the terminal olefin comprises, is primarily composed of, or is composed of: a terminal C3-C 20 Alkenes, terminal C3-C 19 Alkenes, terminal C3-C 18 Alkenes, terminal C3-C 17 Alkenes, terminal C3-C 16 Alkenes, terminal C3-C 15 Alkenes, terminal C3-C 14 Alkenes, terminal C3-C 13 Alkenes, terminal C3-C 12 Alkenes, terminal C3-C 11 Alkenes, terminal C3-C 10 Alkenes, terminal C3-C9 alkenes, terminal C3-C8 alkenes, or terminal C3-C7 alkenes.
[0207] Aspect 11. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of or is composed of a straight-chain terminal alkyne.
[0208] Aspect 12. The compound of any one of the preceding aspects, wherein the terminal olefin comprises, is mainly composed of or is composed of a straight-chain terminal olefin.
[0209] Aspect 13. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of or is composed of branched terminal alkynes.
[0210] Aspect 14. The compound of any one of the preceding aspects, wherein the terminal olefin comprises, is mainly composed of or is composed of branched terminal olefins.
[0211] Aspect 15. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises two or more triple bonds, one or more double bonds (e.g., enyne) or combinations thereof.
[0212] Aspect 16. The compound of any one of the preceding aspects, wherein the terminal olefin comprises two or more double bonds.
[0213] Aspect 17. The compound of any one of the preceding aspects, wherein the terminal alkyne and / or the terminal olefin comprises heteroatoms.
[0214] Aspect 18. The compound as described in any of the preceding aspects, wherein the heteroatom is oxygen.
[0215] Aspect 19. The compound of any one of the preceding aspects, wherein the terminal alkyne and / or the terminal olefin comprises an ether moiety, a ketone moiety, or both an ether moiety and a ketone moiety, wherein optionally, the terminal olefin does not contain an acrylate or an acrylate group (C=C-COOR).
[0216] Aspect 20. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of, or is composed of: a compound of formula (I). Where n is an integer selected from 0 to 5 or 0 to 4; and where R 1 Selected from hydrogen or C1-C6 alkyl groups, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc. Alternatively, R 1 Optional from C3-C 12 cycloalkyl, C3-C 10 Cycloalkyl or C3-C7 cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, etc.
[0217] Aspect 21. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of, or is composed of: a compound of formula (II). Where n is an integer selected from 0 to 5 or 0 to 4; where m is an integer selected from 0 to 5 or 0 to 4; and where R 2 It is selected from hydrogen or C1-C6 alkyl, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc.
[0218] Aspect 22. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of, or is composed of: a compound of formula (III) Where n is an integer selected from 0 to 5 or 0 to 4.
[0219] Aspect 23. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of, or is composed of: Where n is an integer selected from 0 to 5 or 0 to 4; and where m is an integer selected from 0 to 5 or 0 to 4.
[0220] Aspect 24. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of, or is composed of: Where n is an integer selected from 0 to 5, 0 to 4, or 1 to 4.
[0221] Aspect 25. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of, or is composed of: Where n is an integer selected from 0 to 5 or 0 to 4; and where R 3 It is hydrogen or C1-C6 alkyl, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc.
[0222] Aspect 26. The compound of any one of the preceding aspects, wherein the terminal alkyne comprises, is mainly composed of, or is composed of: a compound of formula (VII). Where n is an integer selected from 0 to 5; and where R 4 It is hydrogen or C1-C6 alkyl, such as methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc.
[0223] Aspect 27. The compound of any one of the preceding aspects, wherein the terminal olefin comprises, is substantially composed of, or is composed of: a compound of formula (A). Where m is an integer selected from 0 to 4, such as 3 or 4 (for example, m is 3 for hepadiene and 4 for octadiene).
[0224] Aspect 28. The compound of any one of the preceding aspects, wherein the terminal olefin comprises, is substantially composed of, or is composed of: a compound of formula (B). Where m is an integer selected from 0 to 4, such as 2 or 3 (for example, m is 2 for hepadiene and 3 for octadiene).
[0225] Aspect 29. The compound of any one of the preceding aspects, wherein the terminal olefin comprises, is substantially composed of, or is composed of: a compound of formula (C). Where m is 0, 1, 2 or 3, and n is 0, 1, 2 or 3, wherein optionally, for hepadiene, m + n = 2, and for octadiene, m + n = 3.
[0226] Aspect 30. The compound of any one of the preceding aspects, wherein the terminal olefin comprises, is substantially composed of, or is composed of: a compound of formula (D). Where n is an integer selected from 0 to 5 or 0 to 4; and where R 1 Choose from hydrogen, C1-C6 alkyl or C3-C 12 Group consisting of cycloalkyl groups.
[0227] Aspect 31. The compound of any one of the preceding aspects, wherein the terminal alkyne and / or terminal olefin comprises, is mainly composed of, or is composed of:
[0228] Aspect 32. The compound as described in any of the preceding aspects, wherein the terminal alkyne and / or terminal olefin comprises, is substantially composed of, or is composed of: propylene, 1-butene, 1-pentene, 1-hexene, 1-heptene, 1-octene, 1,3-butadiene, 1,4-pentadiene, 1,5-hexadiene, 1,6-heptadiene, 1,7-octadiene, 3-methyl-1-butene, 4-methyl-1-pentene, 5-methyl-1-hexene, 6-methyl-1-heptene, 7 -Methyl-1-octene, 3-methyl-1-pentene, 4-methyl-1-hexene, 5-methyl-1-heptene, 6-methyl-1-octene, 3,3-dimethyl-1-butene, 4,4-dimethyl-1-pentene, 5,5-dimethyl-1-hexene, 6,6-dimethyl-1-heptene, 7,7-dimethyl-1-octene, 3,3-dimethyl-1-pentene, 3,3-dimethyl-1-hexene, 3,3-dimethyl-1-heptene, 3,3-dimethyl-1-octene.
[0229] Aspect 33. The compound of any one of the preceding aspects, wherein the terminal alkyne and / or terminal olefin comprises, is mainly composed of, or is composed of: 1-butene, 1-hexene, 1-octene, 1,3-butadiene, 1,4-pentadiene, 1,5-hexadiene, 1,6-heptadiene, and 1,7-octadiene.
[0230] Aspect 34. A composition comprising, consisting mainly of, or consisting of any of the compounds and additives as described in any of the preceding aspects.
[0231] Aspect 35. The composition of any one of the preceding aspects, wherein the compound of any one of the preceding aspects can be used as both a brittleness inhibitor and a flavoring agent.
[0232] Aspect 36. The composition of any one of the preceding aspects, wherein the composition further comprises, is mainly composed of, or is composed of, a flavoring agent, wherein the flavoring agent is different from the compound of any one of the preceding aspects (e.g., compound (I) and compound (VIII)).
[0233] Aspect 37. The composition of any one of the preceding aspects, wherein the compound (e.g., a terminal alkyne or a terminal olefin) acts as a brittleness inhibitor but not as a flavoring agent (e.g., the concentration of the brittleness inhibitor is insufficient to produce a detectable odor, the brittleness inhibitor is not an odorous compound, etc.).
[0234] Aspect 38. The composition of any one of the preceding aspects, wherein the flavoring detection threshold (ODT) of the crisping inhibitor is equal to or greater than a value that effectively prevents the crisping inhibitor from affecting the flavoring provided by the flavoring agent.
[0235] Aspect 39. The composition of any one of the preceding aspects, further comprising an alkyne (which may be a non-terminal alkyne), such as a flavoring agent, wherein optionally, said alkyne comprises, is mainly composed of, or is composed of: a compound of formula (VIII). Where R 5 and R 6 Each can be independently hydrogen, C1-C6 alkyl, or C1-C6 cycloalkyl. C1-C6 can include methyl, ethyl, propyl, isopropyl, isobutyl, tert-butyl, etc.
[0236] Aspect 40. The composition of any one of the preceding aspects, wherein the compound of formula (VIII) comprises, is mainly composed of, or is composed of the compounds listed in the following table:
[0237] Aspect 41. The composition of any of the preceding aspects, wherein the concentration of the flavoring agent in the composition is less than or equal to the THT concentration required to produce a similar or equivalent odor.
[0238] Aspect 42. The composition of any of the preceding aspects, wherein the concentration of the flavoring agent in the composition is greater than the THT concentration required to produce a similar odor.
[0239] Aspect 43. The composition of any one of the preceding aspects, wherein the additive is dispersed in the flavoring agent, or the flavoring agent is dispersed in the additive.
[0240] Aspect 44. The composition as described in any of the preceding aspects, wherein the additive is an odorous additive.
[0241] Aspect 45. The composition of any one of the preceding aspects, wherein (A) the additive comprises, is mainly composed of, or is composed of: methacrylic acid, C1-C6 alkyl acrylates or combinations thereof; or (B) the additive does not comprise methacrylic acid, C1-C6 alkyl acrylates or combinations thereof.
[0242] Aspect 46. The composition of any one of the preceding aspects, wherein the additive comprises an odorless additive.
[0243] Aspect 47. The composition of any one of the preceding aspects, wherein the additive comprises, is mainly composed of, or is composed of a hydrogen embrittlement inhibitor.
[0244] Aspect 48. The composition of any one of the preceding aspects, wherein the additive is a stabilizer (i.e., a compound that prevents or delays the chemical degradation of fluids and / or compounds, such as the compound of any one of the preceding aspects).
[0245] Aspect 49. The composition of any one of the preceding aspects, wherein the stabilizer comprises, is mainly composed of, or is composed of an antioxidant, a free radical inhibitor, or a combination thereof.
[0246] Aspect 50. The composition of any one of the preceding aspects, wherein the stabilizer comprises, is primarily composed of, or is composed of (but is not limited to) the following: vitamin C or a derivative thereof (e.g., ascorbyl palmitate, ascorbyl acetate, etc.), tocopherol or a derivative thereof (e.g., vitamin E, vitamin E acetate, etc.), vitamin A or a derivative thereof (e.g., vitamin A palmitate, etc.), phenylbenzylamine, formic acid, acetic acid, benzoic acid, sorbic acid, butylated hydroxytoluene (tert-butylated hydroxytoluene (BHT)), butylated hydroxyanisole (BOA or BHA), 4-tert-butylcatechol (TBC), tert-butylated hydroxyanisole, 4-methoxyphenol (hydroquinone monomethyl ether (MeHQ)), 2-methoxyphenol (guaiacol), 2,6-di-tert-butylphenol (2,6-DTBP), 2,5-di-tert-butylphenol (catechol), phenyl-1,2-diol (catechol). Benzene-1,4-diol (hydroquinone, HQ), Benzene-1,3-diol (resorcinol), 2-ethylphenol, 4-ethylphenol, mono-tert-butylhydroquinone (MTBHQ), 2,5-di-tert-butylhydroquinone (DTBHQ), tert-butylhydroquinone (TBHQ), toluene-hydroquinone (THQ), (2,2,6,6-tetramethylpiperidin-1-yl)oxy (TEMPO) and its derivatives, N,N-dibenzylhydroxylamine (DBHA) Hexamethylenetetramine (methylamine or HMTA or HMT), p-benzoquinone (p-Bq), o-benzoquinone (O-Bq), N,N-dimethylisopropanolamine (DMPA), phenothiazine (PTZ), 2,4-dinitrophenol (DNP), 2,4-dinitro-6-sec-butylphenol (DNBP), 2,6-dinitro-p-cresol, 1,4-phenylenediamine, N,N-dimethylaniline, melatonin, uric acid, glutathione, or combinations thereof.
[0247] Aspect 51. The composition of any one of the preceding aspects, wherein the additive is a diluent of the compound of any one of the preceding aspects.
[0248] Aspect 52. The composition of any one of the preceding aspects, wherein the additive comprises, is mainly composed of, or is composed of: C5-C8 saturated hydrocarbons (e.g., pentane, cyclopentane, hexane, cyclohexane, heptane, cycloheptane, octane and / or fluorinated hydrocarbons, e.g., PFC-116, PFC-c216, PFC218 or PFC-318).
[0249] Aspect 53. The composition of any one of the preceding aspects, wherein the additive comprises, is mainly composed of, or is composed of: 2-methylpropyl methacrylate (isobutyl methacrylate), allyl acrylate, allyl methacrylate, butyl acrylate, butyl methacrylate, ethyl methacrylate, ethyl acrylate, isobutyl acrylate, methyl acrylate, methyl methacrylate, propyl methacrylate, propyl acrylate, propargyl alcohol, 1-cyclohexene-1-carboxaldehyde, 2-methylpropanal (isobutyraldehyde), 3-butenal, 3-methylbutyraldehyde (isopental), isopentanal (isoval) 5-Methyl-2-pyrrolealdehyde, butanal / butylaldehyde, cyclohexanal, cyclopentan-1-enaldehyde, cyclopentane-formaldehyde (cyclopentanal), acetone (acetaldehyde), pentanal / valeraldehyde, 2-methyl-2-butene, cis-2-butene, cis-2-pentene, diisobutene, isobutene, trans-2-butene, trans-2-pentene, vinylacetylene (butenyne), 2-methylpropionic acid, butyric acid, isovaleric acid, lactic acid, pentanoic acid / valeric acid Propionic acid, 1-butyne, 1-octyne, 2-butyne, 2-hexyne, 2-octyne, 2-heptyne, 3-heptyne, 3-octyne, 4-methyl-1-pentyne, 4-methyl-2-pentyne, acetylene, vinylacetylene (butenyne), allyl methyl ether, diallyl ether, cyclohexene, ethylene, cyclohexane, 1,2-butadiene (methylpropadiene), 1,3-cyclohexadiene, 1,4-pentadiene, 1,5-cyclooctadiene (cis / trans-1,5-cyclooctadiene), 1,5-cyclooctadiene (cis-1,5-cyclooctadiene), 1,5-cyclooctadiene (trans-1,5-cyclooctadiene), 2,3-dimethyl-1,3-butadiene, 2-methyl-1,3-butadiene (isoprene), 3 -Methyl-1,5-cyclooctadiene, methyl allyl sulfide, 2,3-butanedione (diacetyl), 2,4-pentanedione (acetylacetone), hexane-2,5-dione, pentane-2,3-dione, ethyl acetate, methyl acetate, 3-methylindole (skatole), 3-hydroxybut-2-one (acetoin), 5-hydroxyoctane-4-one (butazoin), cyclohexylthiol, ethanethiol (EM), isopropanethiol (IBM), methanethiol (MM), propanethiol, sec-butanethiol, tert-butanethiol (TBM), 5-vinylbicyclo[2.2.1]hept-2-ene (5-vinyl-2-norbornene), 5-ethylidenebicyclo[2.2.1]hept-2-ene (5-ethylidene-2-norbornene), bicyclo[2.2.1] Hepta-2-ene (norbornene), acetic acid, formic acid, diethyl selenide, diethyl selenide, dimethyl selenide, tert-butyl selenool, carbonyl sulfide, diethyl disulfide, diethyl sulfide (DES), diisopropyl sulfide, dimethyl disulfide (DMDS), dimethyl sulfide (DMS), methyl ethyl sulfide (MES), tetrahydrothiophene (THT), tert-butyl mercaptan (TBM), N-methyl-2-pyrrolidone (NMP), Scentinel® T gas flavoring agent, Scentinel® S-50 gas flavoring agent, Scentinel® P gas flavoring agent, Scentinel® O-10 gas flavoring agent, Scentinel® N gas flavoring agent, Scentinel® H-85 gas flavoring agent, Scentinel® F-50 gas flavoring agent, Scentinel® F-40 gas flavoring agent, Scentinel® F-35 gas flavoring agent, Scentinel® Scentinel® F-25 gaseous flavoring agent, Scentinel® F-20 gaseous flavoring agent, Scentinel® E gaseous flavoring agent, Scentinel® A gaseous flavoring agent, Scentinel® TB gaseous flavoring agent, Scentinel® S-20 gaseous flavoring agent, Scentinel® T-50 gaseous flavoring agent, and Scentinel® N-4 gaseous flavoring agent.
[0250] Aspect 54. The composition of any one of the preceding aspects, wherein the amount of the compound (e.g., terminal alkynes and / or terminal olefins) in the composition is at least 10% by weight, at least 20% by weight, or at least 30% by weight, 40% by weight, 50% by weight, 60% by weight, 70% by weight, 80% by weight, or 90% by weight, based on the total weight of the composition.
[0251] Aspect 55. The composition of any of the preceding aspects, wherein the compound comprises two or more terminal alkynes, and the two or more terminal alkynes are present in the composition in a total amount of at least 1% by weight, at least 5% by weight, at least 10% by weight, at least 20% by weight, at least 30% by weight, at least 40% by weight, at least 50% by weight, at least 60% by weight, at least 70% by weight, at least 80% by weight, or at least 90% by weight, based on the total weight of the composition (e.g., if 20 g of the first terminal alkyne and 30 g of the second terminal alkyne are present in a composition with a total weight of 100 g, then the first and second terminal alkynes are present in the composition in a total amount of 50% by weight).
[0252] Aspect 56. The composition of any one of the preceding aspects, wherein the compound comprises two or more terminal olefins, and the two or more terminal olefins are present in the composition in a total amount of at least 1% by weight, at least 5% by weight, at least 10% by weight, at least 20% by weight, at least 30% by weight, at least 40% by weight, at least 50% by weight, at least 60% by weight, at least 70% by weight, at least 80% by weight, or at least 90% by weight, based on the total weight of the composition (e.g., if 20 g of the first terminal olefin and 30 g of the second terminal olefin are present in a composition with a total weight of 100 g, then the first and second terminal olefins are present in the composition in a total amount of 50% by weight).
[0253] Aspect 57. The composition of any one of the preceding aspects, wherein the compound comprises one or more terminal olefins and one or more terminal olefins, and the one or more terminal olefins are present in the composition in an amount of at least 1% by weight, at least 5% by weight, at least 10% by weight, at least 20% by weight, at least 30% by weight, at least 40% by weight, at least 50% by weight, at least 60% by weight, at least 70% by weight, at least 80% by weight, or at least 90% by weight, based on the total weight of the composition (e.g., if 20 g of terminal olefin and 30 g of terminal alkyne are present in a composition with a total weight of 100 g, then the terminal olefin and the terminal alkyne are present in the composition in an amount of 50% by weight).
[0254] Aspect 58. A treated fluid comprising, consisting primarily of, or consisting of: (i) a fluid, such as a gas; and (ii) a compound or composition as described in any of the preceding aspects, wherein the compound or composition is dispersed in the fluid.
[0255] Aspect 59. The treated fluid as described in any of the preceding aspects, wherein the compound or the composition is uniformly or non-uniformly dispersed in the fluid.
[0256] Aspect 60. The treated fluid as described in any of the preceding aspects, wherein the compound or composition as described in any of the preceding aspects is a flavoring agent for the fluid.
[0257] Aspect 61. The treated fluid as described in any of the preceding aspects, wherein the compound or composition as described in any of the preceding aspects is present in the treated fluid at a concentration of 1,000 mg / m³. 3 n or lower, 900 mg / m 3 n or lower, 800 mg / m 3 n or lower, 700 mg / m 3 n or lower, 600 mg / m3 n or lower, 500 mg / m 3 n or lower, 400 mg / m 3 n or lower, 300 mg / m 3 n or lower, 200 mg / m 3 n or lower, 100 mg / m 3 n or lower, 90 mg / m 3 n or lower, 80 mg / m 3 n or lower, 70 mg / m 3 n or lower, 60 mg / m 3 n or lower, 50 mg / m 3 n or lower, 40 mg / m 3 n or lower, 30 mg / m 3 n or lower, 20 mg / m 3 n or lower, or 10 mg / m³ 3 n or lower.
[0258] Aspect 62. The treated fluid as described in any of the preceding aspects, wherein the compound or composition as described in any of the preceding aspects is present in the treated fluid at a concentration of at least 0.1 mg / m³. 3 n, at least 0.5 mg / m 3 n, at least 1 mg / m 3 n, at least 2 mg / m 3 n, at least 3 mg / m 3 n, at least 4 mg / m 3 n, at least 5 mg / m 3 n, at least 6 mg / m 3 n, at least 7 mg / m 3 n, at least 8 mg / m 3 n, at least 9 mg / m 3 n, or at least 10 mg / m 3 n.
[0259] Aspect 63. The treated fluid as described in any of the preceding aspects, wherein the compound or composition as described in any of the preceding aspects is present in the treated fluid at a concentration of about 1 mg / m³. 3 n to approximately 1,000 mg / m 3 n, approximately 1 mg / m 3 n to approximately 900 mg / m 3 n, approximately 1 mg / m 3 n to approximately 800 mg / m 3 n, approximately 1 mg / m 3 n to approximately 700 mg / m3 n, approximately 1 mg / m 3 n to approximately 600 mg / m 3 n, approximately 1 mg / m 3 n to approximately 500 mg / m 3 n, approximately 1 mg / m 3 n to approximately 400 mg / m 3 n, approximately 1 mg / m 3 n to approximately 300 mg / m 3 n, approximately 1 mg / m 3 n to approximately 200 mg / m 3 n, approximately 1 mg / m 3 n to approximately 100 mg / m 3 n, approximately 1 mg / m 3 n to approximately 90 mg / m 3 n, approximately 1 mg / m 3 n to approximately 80 mg / m 3 n, approximately 1 mg / m 3 n to approximately 70 mg / m 3 n, approximately 1 mg / m 3 n to approximately 60 mg / m 3 n, approximately 1 mg / m 3 n to approximately 50 mg / m 3 n, approximately 1 mg / m 3 n to approximately 40 mg / m 3 n, approximately 1 mg / m 3 n to approximately 30 mg / m 3 n, approximately 1 mg / m 3 n to approximately 20 mg / m 3 n, or approximately 1 mg / m 3 n to approximately 10 mg / m 3 n.
[0260] Aspect 64. The treated fluid as described in any of the preceding aspects, wherein the compound or composition as described in any of the preceding aspects is present in the treated fluid at a concentration of about 1,000 mg / m³. 3 n to approximately 8,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 3,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 4,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 1,000 mg / m3 n to approximately 6,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 3,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 4,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 1,000 mg / m 3 n to approximately 5,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 5,000 mg / m 3 n, or approximately 3,000 mg / m 3 n to approximately 5,000 mg / m 3 n.
[0261] Aspect 65. The treated fluid as described in any of the preceding aspects, wherein the treated fluid is fuel for a fuel cell or other device or system.
[0262] Aspect 66. A method of treating a fluid, the method comprising, consisting primarily of, or consisting of: providing a fluid and contacting (i) the fluid, such as a gas, with (ii) a compound or composition as described in any of the preceding aspects to form a treated fluid.
[0263] Aspect 67. The method of any of the preceding aspects, wherein the fluid and / or the treated fluid is present in a fuel distribution system (e.g., any fuel supply infrastructure (e.g., fuel storage, fuel distribution, fuel delivery, etc.)).
[0264] Aspect 68. The method of any of the preceding aspects, the method further comprising placing the fluid and / or the treated fluid in a fuel distribution system (e.g., any fuel supply infrastructure (e.g., fuel storage, fuel distribution, fuel delivery, etc.)).
[0265] Aspect 69. The method as described in any of the preceding aspects, wherein providing the fluid includes capturing the fluid.
[0266] Aspect 70. The method as described in any of the preceding aspects, the method further comprising pressurizing the treated fluid, storing the treated fluid, or a combination thereof.
[0267] Aspect 71. The method of any of the preceding aspects, wherein the compound or the composition is in a liquid phase, a gas phase or a combination thereof before, during and / or after contact between the fluid and the compound or composition.
[0268] Aspect 72. The method of any of the preceding aspects, wherein contact between the fluid and the compound or the fluid and the composition comprises dispensing the compound or composition using a liquid metering device.
[0269] Aspect 73. The method of any of the preceding aspects, wherein contact between the fluid and the compound or composition comprises atomizing the compound or composition.
[0270] Aspect 74. The method of any of the preceding aspects, wherein providing the fluid comprises providing a container for disposing of the fluid, and wherein contact between the fluid and the compound or composition comprises disposing of the compound or composition in the container.
[0271] Aspect 75. The method of any of the preceding aspects, wherein providing the fluid comprises providing a first material flow containing the fluid, and wherein contacting the fluid with the compound or composition comprises contacting the first material flow with a second material flow containing the compound or composition.
[0272] Aspect 76. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid is a gas (at atmospheric pressure and room temperature).
[0273] Aspect 77. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid comprises, is primarily composed of, or is composed of fuel gas.
[0274] Aspect 78. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid comprises, is primarily composed of, or is composed of hydrogen (H2).
[0275] Aspect 79. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid comprises, is primarily composed of, or is composed of natural or synthetic combustible gases.
[0276] Aspect 80. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid comprises, is primarily composed of, or is composed of: natural gas, LNG (liquefied natural gas), liquefied petroleum gas (LPG), municipal gas, heating gas, or combinations thereof.
[0277] Aspect 81. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid comprises, is primarily composed of, or is composed of methane, ethane, ethylene, acetylene, propane, propylene, butane, isobutane, butene, pentane, or combinations thereof.
[0278] Aspect 82. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid comprises, is mainly composed of, or is composed of: water gas, synthesis gas, reformer gas, producer gas, coke gas, industrial gas (e.g., nitrogen, oxygen, argon, helium, etc.) or combinations thereof.
[0279] Aspect 83. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid comprises, is primarily composed of, or is composed of a non-combustible gas.
[0280] Aspect 84. The compound, composition, treated fluid, or method as described in any of the preceding aspects, wherein the fluid comprises, is mainly composed of, or is composed of carbon monoxide, carbon dioxide, or a combination thereof.
[0281] Aspect 85. A method for generating energy, the method comprising, consisting primarily of, or consisting of: providing a fuel cell, the fuel cell including an anode; and contacting the anode with a treated fluid as described in any of the preceding aspects.
[0282] Aspect 86. The method of any of the preceding aspects, wherein contact between the anode and the treated fluid produces an oxidized treated fluid.
[0283] Aspect 87. The method of any one of the preceding aspects, further comprising removing the compound (e.g., one or more terminal alkynes) of any one of the preceding aspects from the treated fluid.
[0284] Aspect 88. The method as described in any of the preceding aspects, further comprising removing the compound from the oxidized treated fluid.
[0285] Aspect 89. The method of any of the preceding aspects, wherein the removal of the compound (e.g., one or more terminal alkynes) of any of the preceding aspects is carried out at least in part using any of the equipment or techniques provided herein, including but not limited to the use of catalytic decomposition, adsorption or absorption media, water traps, solvent traps, etc.
[0286] Aspect 90. The method of any one of the preceding aspects, wherein at least a portion of the compound or composition of any one of the preceding aspects can be consumed by the fuel cell, thereby optionally improving the performance of the fuel cell, increasing the energy produced by the fuel cell, or a combination thereof, relative to a fuel cell operated with a treated fluid in the absence of the compound or composition of any one of the preceding aspects.
[0287] Aspect 91. A method for transporting or storing materials, the method comprising, consisting primarily of, or consisting of: (i) providing a treated fluid as described in any of the preceding aspects, and (ii) placing the treated fluid in a device at least partially formed of metal.
[0288] Aspect 92. The method of any of the preceding aspects, wherein the device comprises, is substantially composed of or is composed of conduits or storage containers.
[0289] Aspect 93. The composition or method as described in any of the preceding aspects, wherein the composition or compound as described in any of the preceding aspects prevents or delays hydrogen embrittlement of the metal (when the compound or composition has a positive substitution effect as defined in Example 1, such as at least 0.5 eV, at least 0.75 eV, at least 1 eV, at least 1.5 eV, at least 2 eV, at least 2.5 eV, at least 3 eV, at least 3.5 eV or at least 4 eV, the compound or composition “prevents or delays hydrogen embrittlement of the alloy”).
[0290] Aspect 94. The composition or method of any of the preceding aspects, wherein the composition or compound of any of the preceding aspects (i) increases the fracture toughness of a metal in contact with the same composition without embrittlement inhibitors by at least 3%, at least 5%, at least 10%, at least 15%, at least 20%, at least 30%, at least 40%, or at least 50%; and / or (ii) extends the service life of the same equipment for conveying or storing fluids without hydrogen embrittlement inhibitors by at least 5%, at least 10%, at least 15%, or at least 20%.
[0291] Aspect 95. A system comprising (i) a sensor and (ii) a compound or composition as described in any of the preceding aspects.
[0292] Aspect 96. The system of any one of the preceding aspects, wherein the sensor is coupled to, or configured to be coupled to, a device formed at least in part by: metal (e.g., a pipe), a fuel supply device, a fuel cell, another component of a fuel cell system, any appliance using hydrogen as fuel, or any component of an appliance using hydrogen as fuel.
[0293] Aspect 97. The system of any one of the preceding aspects, wherein the sensor includes circuitry programmed to shut down a device, fuel cell, appliance or other system or component thereof in the event of a leak.
[0294] Aspect 98. The system as described in any of the preceding aspects, wherein the sensor is configured to allow the use of any compound as described in the preceding aspects at concentrations undetectable by ordinary persons.
Claims
1. A treated fluid composition comprising: (i) fluid; (ii) a hydrogen embrittlement inhibitor dispersed in the fluid, the hydrogen embrittlement inhibitor comprising dienes and / or terminal alkynes; (iii) Optionally, additives; and (iv) Optionally, a flavoring agent different from the inhibitor.
2. The composition of claim 1, wherein the fluid comprises hydrogen (H2), and at least 10 mol%, at least 20 mol%, at least 30 mol%, at least 50 mol%, at least 75 mol%, at least 85 mol%, at least 90 mol%, at least 95 mol%, at least 97 mol%, at least 98 mol%, or at least 99 mol% of the fluid is said hydrogen (H2).
3. The composition of claim 1, wherein the fluid comprises hydrogen (H2), and 10 mol% to 40 mol%, 10 mol% to 30 mol%, 10 mol% to 25 mol%, 15 mol% to 30 mol%, or 15 mol% to 25 mol% of the fluid is said hydrogen (H2).
4. The composition according to any one of claims 1 to 3, wherein the terminal alkyne comprises a mono-1-alkyne, a diyne, an enyne, or a combination thereof.
5. The composition of any one of claims 1 to 4, wherein the hydrogen embrittlement inhibitor has a hydrogen replacement efficacy of at least 0.1 eV.
6. The composition of any one of claims 1 to 5, wherein the hydrogen embrittlement inhibitor is present in a sufficient concentration such that the hydrogen embrittlement inhibitor also functions as a flavoring agent.
7. The composition of any one of claims 1 to 6, wherein the hydrogen embrittlement inhibitor comprises hex-1-yne, hept-1-yne, oct-1-yne, hept-1,6-diyne, hex-1,5-diyne and oct-1,7-diyne, 4-methyl-pent-1-yne, 5-methyl-hex-1-yne, cyclopropylacetylene, 3,3-dimethyl-but-1-yne, 1,3-butadiene, 1,5-hexadiene, 1,7-octadiene or any combination thereof.
8. The composition of any one of claims 1 to 7, wherein the hydrogen embrittlement inhibitor comprises 1,5-hexadiene.
9. The composition of any one of claims 1 to 8, wherein the hydrogen embrittlement inhibitor comprises hept-1,6-diyne, hex-1,5-diyne and oct-1,7-diyne or a combination thereof.
10. The composition of any one of claims 1 to 9, wherein the hydrogen embrittlement inhibitor comprises 3,3-dimethyl-but-1-yne.
11. The composition of any one of claims 1 to 10, wherein the hydrogen embrittlement inhibitor is present in the treated fluid composition at a concentration of about 1,000 mg / m³. 3 n to approximately 8,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 3,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 4,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 1,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 3,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 4,000 mg / m 3 n to approximately 6,000 mg / m 3 n, approximately 1,000 mg / m 3 n to approximately 5,000 mg / m 3 n, approximately 2,000 mg / m 3 n to approximately 5,000 mg / m 3 n, or approximately 3,000 mg / m 3 n to approximately 5,000 mg / m 3 n.
12. The composition of any one of claims 1 to 10, wherein the hydrogen embrittlement inhibitor is present in the treated fluid composition at a concentration of about 100 mg / m³. 3 n to approximately 8,000 mg / m 3 n, approximately 100 mg / m 3 n to approximately 5,000 mg / m 3 n, approximately 100 mg / m 3 n to approximately 2,500 mg / m 3 n, approximately 100 mg / m 3 n to approximately 1,000 mg / m 3 n, approximately 500 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 500 mg / m 3 n to approximately 5,000 mg / m 3 n, approximately 500 mg / m 3 n to approximately 2,500 mg / m 3 n, approximately 500 mg / m 3 n to approximately 1,000 mg / m 3 n, approximately 1,000 mg / m 3 n to approximately 8,000 mg / m 3 n, approximately 1,000 mg / m 3 n to approximately 5,000 mg / m 3 n, or approximately 1,000 mg / m 3 n to approximately 2,500 mg / m 3 n.
13. The composition according to any one of claims 1 to 12, wherein (iv) the flavoring agent is present in the composition.
14. The composition of claim 13, wherein the flavoring agent comprises hex-1-yne, hex-2-yne, hepta-1-yne, hepta-2-yne, hepta-3-yne, oct-1-yne, oct-2-yne, oct-3-yne, oct-4-yne, 6-methylhepta-2-yne, 7-methyloct-3-yne, 2-methyloct-4-yne, hex-1-en-5-yne, hepta-1-en-6-yne, 5-methylhex-1-yne, methyl acrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, cyclohexene, or combinations thereof.
15. The composition of claim 13, wherein the flavoring agent comprises hex-1-yne, hex-2-yne, hepta-2-yne, or a combination thereof.
16. The composition of any one of claims 1 to 15, wherein (iv) the flavoring agent is present in the treated fluid composition at a concentration of about 1 mg / m³. 3 n to approximately 1,000 mg / m 3 n, approximately 1 mg / m 3 n to approximately 900 mg / m 3 n, approximately 1 mg / m 3 n to approximately 800 mg / m 3 n, approximately 1 mg / m 3 n to approximately 700 mg / m 3 n, approximately 1 mg / m 3 n to approximately 600 mg / m 3 n, approximately 1 mg / m 3 n to approximately 500 mg / m 3 n, approximately 1 mg / m 3 n to approximately 400 mg / m 3 n, approximately 1 mg / m 3 n to approximately 300 mg / m 3 n, approximately 1 mg / m 3 n to approximately 200 mg / m 3 n, approximately 1 mg / m 3 n to approximately 100 mg / m 3 n, approximately 1 mg / m 3 n to approximately 90 mg / m 3 n, approximately 1 mg / m 3 n to approximately 80 mg / m 3 n, approximately 1 mg / m 3 n to approximately 70 mg / m 3 n, approximately 1 mg / m 3 n to approximately 60 mg / m 3 n, approximately 1 mg / m 3 n to approximately 50 mg / m 3 n, approximately 1 mg / m 3 n to approximately 40 mg / m 3 n, approximately 1 mg / m 3 n to approximately 30 mg / m 3 n, approximately 1 mg / m 3 n to approximately 20 mg / m 3 n, or approximately 1 mg / m 3 n to approximately 10 mg / m 3 n.
17. The composition of any one of claims 1 to 15, wherein (iv) the flavoring agent is present in the treated fluid composition at a concentration of about 1 mg / m³. 3 n to approximately 50 mg / m 3 n, approximately 1 mg / m 3 n to approximately 40 mg / m 3 n, approximately 1 mg / m 3 n to approximately 30 mg / m 3 n, approximately 1 mg / m 3 n to approximately 20 mg / m 3 n, approximately 1 mg / m 3 n to approximately 10 mg / m 3 n, approximately 2 mg / m 3 n to approximately 50 mg / m 3 n, approximately 2 mg / m 3 n to approximately 40 mg / m 3 n, approximately 2 mg / m 3 n to approximately 30 mg / m 3 n, approximately 2 mg / m 3 n to approximately 20 mg / m 3 n, approximately 2 mg / m 3 n to approximately 15 mg / m 3 n, approximately 5 mg / m 3 n to approximately 50 mg / m 3 n, approximately 5 mg / m 3 n to approximately 40 mg / m 3 n, approximately 5 mg / m 3 n to approximately 30 mg / m 3 n, approximately 5 mg / m 3 n to approximately 20 mg / m 3 n, or approximately 5 mg / m 3 n to approximately 15 mg / m 3 n.
18. The composition according to any one of claims 1 to 17, wherein the additive (iii) is present in the composition.
19. The composition of claim 18, wherein the additive comprises a stabilizer, an antioxidant, and / or a free radical inhibitor.
20. The composition of claim 18 or 19, wherein the additive comprises a compound having a ketone moiety, a compound having an amine moiety, a compound having an alcohol moiety, a compound having a phenol moiety, or any combination thereof.
21. The composition of any one of claims 18 to 20, wherein the additive comprises isopropanol (IPA), acetone, triethylamine, diethylhydroxylamine (DEHA), o-cresol, m-cresol, p-cresol, 2-ethylphenol, 3-ethylphenol, 4-ethylphenol, 2-methoxy-4-methylphenol (cresol), 2-methoxyphenol, butylated hydroxyanisole (BHA), 2,6-bis(1,1-dimethylethyl)-4-methylphenol (BHT), resorcinol, diphenylamine, 1,4-diazabicyclo[2.2.2]octane (DABCO), 2-butylphenol, 3-methoxyphenol, 2,4-dimethylphenol, 2,6-dimethylphenol, 2-(trifluoromethyl)phenol, 3-(trifluoromethyl)phenol, ethanolamine, dimethylaniline, diethylaniline, or any combination thereof.
22. The composition of any one of claims 18 to 21, wherein the additive comprises: Triethylamine, diethylhydroxylamine (DEHA), 2-ethylphenol, 3-ethylphenol, 2-methoxy-4-methylphenol (cresol), 2-methoxyphenol, butylated hydroxyanisole (BHA), or any combination thereof; or Triethylamine, diethylhydroxylamine (DEHA), 2-ethylphenol, butylated hydroxyanisole (BHA), or any combination thereof.
23. The composition according to any one of claims 1 to 22, wherein the additive (iii) is present in the treated fluid composition at a concentration such that: Based on the weight of the hydrogen embrittlement inhibitor in the composition, or based on the weight of the flavoring agent in the composition, approximately 10 ppmw to approximately 10 wt%, approximately 10 ppmw to approximately 8 wt%, approximately 10 ppmw to approximately 6 wt%, approximately 10 ppmw to approximately 4 wt%, approximately 10 ppmw to approximately 2 wt%, approximately 10 ppmw to approximately 1 wt%, approximately 10 ppmw to approximately 5,000 ppmw, approximately 50 ppmw to approximately 10 wt%, approximately 50 ppmw to approximately 8 wt%, approximately 50 ppmw to approximately 6 wt%, approximately 50 ppmw to approximately 4 wt%, approximately 50 ppmw to approximately 2 wt%, approximately 50 ppmw to approximately 1 wt%, approximately 50 ppmw to approximately 5,000 ppmw, approximately 50 ppmw to approximately 1,000 ppmw, approximately 200 ppmw to approximately 10 wt%, approximately 200 ppmw to approximately 8 wt%, approximately 200 ppmw to approximately 6 wt%, approximately 200 ppmw to approximately 6 wt%, approximately 200 ppmw to approximately 10 wt%, approximately 200 ppmw to approximately 8 wt%, approximately 200 ppmw to approximately 6 wt%, approximately 200 ppmw to approximately 10 ...10 wt%, approximately 200 ppmw to approximately 10 wt%, approximately 200 ppmw to approximately 10 wt%, approximately 20 ppmw to about 4 wt%, about 200 ppmw to about 2 wt%, about 200 ppmw to about 1 wt%, about 200 ppmw to about 5,000 ppmw, or about 200 ppmw to about 2,000 ppmw; or Based on the weight of the hydrogen embrittlement inhibitor in the composition, or based on the weight of the flavoring agent in the composition, approximately 10 ppmw to approximately 1,000 ppmw, approximately 10 ppmw to approximately 900 ppmw, approximately 10 ppmw to approximately 750 ppmw, approximately 10 ppmw to approximately 500 ppmw, approximately 50 ppmw to approximately 1,000 ppmw, approximately 50 ppmw to approximately 750 ppmw, approximately 50 ppmw to approximately 500 ppmw, approximately 200 ppmw to approximately 1,000 ppmw, approximately 200 ppmw to approximately 900 ppmw, approximately 200 ppmw to approximately 750 ppmw, or approximately 200 ppmw to approximately 500 ppmw.
24. The composition of any one of claims 1 to 23, wherein the treated fluid composition is prepared by a method comprising contacting the fluid, the hydrogen embrittlement inhibitor, the additive, and optionally the flavoring agent in any order or sequence.
25. The composition of any one of claims 1 to 24, wherein the treated fluid composition is prepared by a method comprising: The additive, in solid or liquid form, is introduced into the flavoring container through a first sealed inlet; The flavoring agent and the hydrogen embrittlement inhibitor are introduced into the flavoring agent container through the first sealed inlet or the second sealed inlet, and mixed with the additive to form a flavoring agent composition; and At least a portion of the flavoring composition is discharged from the flavoring container through a sealed outlet and comes into contact with the fluid to form the treated fluid composition.
26. The composition of any one of claims 1 to 24, wherein the treated fluid composition is prepared by a method comprising: The additive in liquid form is introduced into a multi-port container; The multi-port container is connected to a flavoring container containing the flavoring agent and the hydrogen embrittlement inhibitor, and the additive is transferred into the flavoring container through a sealed inlet, and the additive is mixed with the flavoring agent and the hydrogen embrittlement inhibitor to form a flavoring composition; Disconnect the multi-port container from the flavoring agent container; as well as At least a portion of the flavoring composition is discharged from the flavoring container through a sealed outlet and comes into contact with the fluid to form the treated fluid composition.
27. The composition of any one of claims 1 to 26, wherein the fluid or the treated fluid composition is present in the fuel distribution system.
28. A method for transporting or storing materials, the method comprising: (i) Providing a treated fluid composition as described in any one of claims 1 to 27; as well as (ii) The treated fluid composition is placed in a device that is at least partially formed of metal.
29. The method of claim 28, wherein the device comprises a conduit.
30. The method of claim 28 or 29, wherein the hydrogen embrittlement inhibitor prevents or delays hydrogen embrittlement of the metal.
31. The method of any one of claims 28 to 30, wherein the service life of said device is at least 10% longer than that of the same device used for transporting or storing fluids that do not contain said hydrogen embrittlement inhibitor.
32. A method for generating energy, the method comprising: Provide a fuel cell, wherein the fuel cell includes an anode; as well as The anode is brought into contact with the treated fluid composition as described in any one of claims 1 to 27; The contact between the anode and the treated fluid composition produces an oxidized treated fluid composition.
33. The method of claim 32, further comprising removing the hydrogen embrittlement inhibitor from the treated fluid composition or the oxidized treated fluid composition.
34. The method of claim 32 or 33, wherein the hydrogen embrittlement inhibitor is at least partially consumed by the fuel cell, thereby improving the performance of the fuel cell, increasing the energy produced by the fuel cell, or a combination thereof, relative to a fuel cell operating with the fluid of the treated fluid composition in the absence of the hydrogen embrittlement inhibitor.
Citation Information
Patent Citations
Adsorber material and method for desulfurization of hydrocarbon gases
EP2337621B1
Wood drier
JP1988006377A
Hot-welding machine
JP1993051864A
Method and apparatus for treating malodorous gas
JP1993295689A
Method for manufacture of lithographic offset printing plate by silver salt diffusion transfer method
JP1994317909A
